{
  "meta": {
    "title": "Numbers_Mini_Test",
    "url": "https://brainandscalpel.vercel.app/numbers-mini-test-8f5bfb9b.html",
    "scrapedAt": "2025-11-30T12:45:12.351Z"
  },
  "questions": [
    {
      "text": "Choose the correct option regarding the storage temperatures of blood components.",
      "choices": [
        {
          "id": 1,
          "text": "RBC 20-22°C, Platelet 2-6°C, FFP -30°C"
        },
        {
          "id": 2,
          "text": "RBC 2-6°C,\tPlatelet 20-22°C, FFP -30°C"
        },
        {
          "id": 3,
          "text": "RBC -30°C,\tFFP 2-6\t°C,\tPlatelet 20-22°C"
        },
        {
          "id": 4,
          "text": "RBC 20-22°C, FFP below -30°C, Platelet 2-6 °C"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The recommended storage temperatures of different blood components is as follows:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Blood component</strong></td>\n<td><strong>Storage temperature</strong></td>\n</tr>\n<tr>\n<td>Whole blood and red blood cells</td>\n<td>2&ndash;6&deg;C</td>\n</tr>\n<tr>\n<td>Fresh frozen plasma</td>\n<td>-30&deg;C or lower</td>\n</tr>\n<tr>\n<td>Cryoprecipitate</td>\n<td>Below -30&deg;C</td>\n</tr>\n<tr>\n<td>\n<p>Albumin</p>\n<p>Freeze-dried factor VIII</p>\n</td>\n<td>2&ndash;8&deg;C</td>\n</tr>\n<tr>\n<td>Platelet</td>\n<td>20&ndash;24&deg;C</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3513",
      "difficulty": "easy"
    },
    {
      "text": "What levels of prolactin are definitely suggestive of prolactinoma?",
      "choices": [
        {
          "id": 1,
          "text": ">50μg/L"
        },
        {
          "id": 2,
          "text": ">100μg/L"
        },
        {
          "id": 3,
          "text": ">150μg/L"
        },
        {
          "id": 4,
          "text": ">200μg/L"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The diagnosis of a <strong>prolactinoma</strong> is highly likely when prolactin levels are <strong>&gt; 200 &mu;g/L</strong>.</p>\n<p>The <strong>normal</strong> range of serum prolactin (PRL) is <strong>5-20 &mu;g/L</strong>. Prolactin levels &lt; 100 &mu;g/L can be due to non-functioning pituitary adenomas or non-neoplastic causes of hyperprolactinemia. MRI brain must be done in all patients with hyperprolactinemia.</p>\n<p>Prolactinoma are tumors arising from the <strong>lactotroph cells</strong> of the <strong>pituitary gland</strong>, they can be classified as <strong>microadenoma</strong>(&lt;1cm in diameter, usually non invasive ) or <strong>macroadenoma</strong>(&gt;1cm, locally invasive to adjacent structures). Clinical features include amenorrhea, infertility, and galactorrhea in women, impotence, loss of libido, infertility in men and if tumor extends beyond sella, there can be visual field defects and other mass effects. </p>\n<p>Treatment - In <strong>asymptomatic</strong> patients and those where <strong>fertility is not desired</strong>, they do <strong>not require treatment</strong> and can be monitored using <strong>regular PRL</strong> measurements and <strong>MRI</strong>.&nbsp;In <strong>symptomatic microadenoma</strong> cases, <strong>oral dopamine agonists</strong> (cabergoline and bromocriptine) form the main treatment for hyperprolactinemia and reduction of tumor volume.&nbsp;For <strong>macroadenoma</strong>, before starting dopamine agonists <strong>visual field testing</strong> is to be done, and reassess it with <strong>MRI changes every 6-12 month</strong> intervals until maximum reduction is achieved, in <strong>unresponsive</strong> cases consider <strong>surgery</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3181",
      "difficulty": "medium"
    },
    {
      "text": "The capsular types of Staphylococcus aureus that are commonly associated with human infections are:",
      "choices": [
        {
          "id": 1,
          "text": "5 & 7"
        },
        {
          "id": 2,
          "text": "5 & 8"
        },
        {
          "id": 3,
          "text": "7 & 8"
        },
        {
          "id": 4,
          "text": "7 & 9"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Most human <strong>Staphylococcus aureus</strong> infections are due to <strong>capsular types 5 and 8. </strong> <strong>&nbsp;</strong></p>\n<p>The polysaccharide microcapsule has antiphagocytic properties. The capsule is a zwitterion and plays a crucial role in abscess formation. &nbsp; &nbsp;</p>\n<p>Note:</p>\n<p>S. aureus has capacity for <strong>intracellular survival</strong> in phagocytes and PMNs. Intracellular environment favors the phenotypic expression of <strong>small colony variants</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6352",
      "difficulty": "medium"
    },
    {
      "text": "What is the shelf life of red blood cells stored with citrate?",
      "choices": [
        {
          "id": 1,
          "text": "28 days"
        },
        {
          "id": 2,
          "text": "35 days"
        },
        {
          "id": 3,
          "text": "45 days"
        },
        {
          "id": 4,
          "text": "21 days"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Shelf life of red blood cells stored with citrate is 21 days.</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: Blood components</h3><table>\n<tbody>\n<tr>\n<td><strong>Component</strong></td>\n<td><strong>Volume     (1 unit)</strong></td>\n<td><strong>Content</strong></td>\n<td><strong>Clinical response, increase in </strong></td>\n<td><strong>Storage temperature</strong></td>\n<td><strong>Shelf-life</strong></td>\n</tr>\n<tr>\n<td>Whole blood</td>\n<td>450 ml</td>\n<td>RBCs, platelets, plasma</td>\n<td>Hb and plasma volume</td>\n<td> </td>\n<td> </td>\n</tr>\n<tr>\n<td>Packed red blood cells (PRBCs)</td>\n<td>300-350 ml</td>\n<td>RBCs</td>\n<td>\n<p>Hb by 1 g/dl</p>\n<p>Hematocrit by 3%</p>\n</td>\n<td>\n<p>1° to 6°C</p>\n</td>\n<td>\n<p>ACD/CPD-21 days, CPD-A-35 days, additive-42 days</p>\n</td>\n</tr>\n<tr>\n<td>Random donor platelets (RDP)</td>\n<td>50-70 ml</td>\n<td>Platelets</td>\n<td>platelet count by 5000-10,000/µL</td>\n<td rowspan=\"2\">20 to 24°C</td>\n<td rowspan=\"2\">5 days</td>\n</tr>\n<tr>\n<td>Single donor apheretic platelets (SDP*)</td>\n<td>200-400 ml</td>\n<td>Platelets</td>\n<td>platelet count by 30,000/µL</td>\n</tr>\n<tr>\n<td>Fresh frozen plasma (FFP)</td>\n<td>200-250 ml</td>\n<td>Coagulation factors, protein C, protein S, anti thrombin</td>\n<td>coagulation factors by 2%</td>\n<td>-40 to -50°C</td>\n<td>1 year</td>\n</tr>\n<tr>\n<td>Cryoprecipitate</td>\n<td>10-15 ml</td>\n<td>fibrinogen, factor VIII, VWF</td>\n<td>80 IU Factor VIII</td>\n<td>-30 °C</td>\n<td>1 year</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1b1f01af443f48ec90792074de2e9c37x1280x1063.JPEG\" alt=\"Pearl Image\"><p>*SDP is obtained by collecting multiple units of platelets from a single donor using apheretic technology. </p>\n<p>1 SDP = 6 RDP</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5486",
      "difficulty": "medium"
    },
    {
      "text": "A 52-year-old man presented with dizziness and infrequent urination. He was diagnosed with stage 4 chronic kidney disease last month.  Investigations reveal metabolic acidosis and hyperkalemia. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Type 1 RTA"
        },
        {
          "id": 2,
          "text": "Type 2 RTA"
        },
        {
          "id": 3,
          "text": "Type 3 RTA"
        },
        {
          "id": 4,
          "text": "Type 4 RTA"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Hyperkalemia</strong> is a characteristic feature of<strong> type 4 RTA </strong>or<strong> generalized distal RTA.</strong> It commonly occurs in patients with chronic kidney disease (CKD).</p>\n<p class=\"p1\">In CKD patients, renal dysfunction results in hyperkalemia only when the GFR is severely impaired (stage 5). <strong>Hyperkalemia</strong> in the <strong>earlier stages</strong> of <strong>CKD</strong> is suggestive of <strong>type 4 RTA.</strong></p>\n<p class=\"p1\">In CKD, volume overload leads to <strong>low</strong> levels of <strong>renin</strong> and, hence, <strong>aldosterone</strong>. This leads to Na<sup>+</sup> loss and K<sup>+</sup> retention in the <strong>distal tubule</strong>. The resultant hyperkalemia causes impaired NH<sub>3</sub> synthesis in the proximal tubule. Hence, H<sup>+</sup> cannot be excreted as NH<sub>4</sub><sup>+</sup> ions. Retained H<sup>+</sup>&nbsp;ions lead to reduced HCO<sub>3</sub><sup>-</sup> production and acidosis.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1183",
      "difficulty": "easy"
    },
    {
      "text": "Which chromosome is involved in myotonic dystrophy?",
      "choices": [
        {
          "id": 1,
          "text": "Chromosome 19"
        },
        {
          "id": 2,
          "text": "Chromosome 20"
        },
        {
          "id": 3,
          "text": "Chromosome 21"
        },
        {
          "id": 4,
          "text": "Chromosome 22"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p class=\"p2\">Chromosome&nbsp;<strong>19&nbsp;</strong>is involved in<strong> myotonic dystrophy</strong>.</p><hr><h3>Related Pearl: Location of Important Genes on Chromosome</h3><table class=\"t1\">\n<tbody>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><strong>Gene</strong></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><strong>Chromosome</strong></p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>P73</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">1p</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Folate transporter</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">21q</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Neuroblastoma</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">1p</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Rhodopsin</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">3</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>VHL</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">3p</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>ADPKD-2</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">4q</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>APC</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">5q</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>MHC</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">6p</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>ARPKD</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">6</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Cystic fibrosis</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">7q</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>MET</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">7</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>RET</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">10</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>WT-1</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">11p</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>vWF</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">12</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Retinoblastoma</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">13q</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>BRCA_1</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">17q</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Fibrillin -1</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">15</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Fibrillin-2</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">5</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>BRCA-2</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">13q</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>NF-1</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">17q</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>P53</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">17</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Dystrophin</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Xp21.2</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><em>NF-2</em></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">22q</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2479",
      "difficulty": "medium"
    },
    {
      "text": "Osmolarity of low osmolarity ORS is",
      "choices": [
        {
          "id": 1,
          "text": "245 mOsm/L"
        },
        {
          "id": 2,
          "text": "295 mOsm/L"
        },
        {
          "id": 3,
          "text": "300 mOsm/L"
        },
        {
          "id": 4,
          "text": "311 mOsm/L"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Osmolarity of low osmolarity ORS is<strong> 245mosm/L</strong>.</p>\n<p>The <strong>low-osmolality</strong> World Health Organization (WHO) oral rehydration solution (ORS) is now the global <strong>standard of care</strong> in the management of acute gastroenteritis.&nbsp;<strong>Oral rehydration is the preferred mode of rehydration</strong> and replacement of ongoing losses except for those with severe dehydration that might necessitate intravenous resuscitation.</p>\n<p>Osmolarity :</p>\n<ul>\n<li>Plasma - 295 mOsm/L</li>\n<li>Standard ORS - 311 mOsm/L</li>\n<li>ReSoMal - 300 mOsm/L</li>\n</ul><hr><h3>Related Pearl: Composition of reduced osmolarity Oral Rehydration Solution (ORS)</h3><p>The composition of reduced-osmolarity oral rehydration solution (ORS) is as follows:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Reduced- osmolarity ORS</strong></td>\n<td><strong>mmol/L</strong></td>\n</tr>\n<tr>\n<td>Sodium&nbsp;</td>\n<td>75&nbsp;</td>\n</tr>\n<tr>\n<td>Chloride</td>\n<td>65</td>\n</tr>\n<tr>\n<td>Glucose (anhydrous)</td>\n<td>75</td>\n</tr>\n<tr>\n<td>Potassium</td>\n<td>20</td>\n</tr>\n<tr>\n<td>Citrate</td>\n<td>10</td>\n</tr>\n<tr>\n<td>Total Osmolarity</td>\n<td><strong>245</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4024",
      "difficulty": "easy"
    },
    {
      "text": "The proximal part right subclavian artery is derived from which aortic arch?",
      "choices": [
        {
          "id": 1,
          "text": "3rd"
        },
        {
          "id": 2,
          "text": "4th"
        },
        {
          "id": 3,
          "text": "5th"
        },
        {
          "id": 4,
          "text": "6th"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The proximal part of&nbsp;<strong>right</strong> subclavian artery is derived from the <strong>4th</strong> aortic arch.</p>\n<p>On the <strong>left</strong> it forms the <strong>arch of aorta</strong> between left common carotid and left subclavian artery.&nbsp;</p><hr><h3>Related Pearl: Derivatives of Various Aortic Arches</h3><p>The <strong>aortic arches</strong> or <strong>pharyngeal arch arteries</strong> are a series of six paired embryological vascular structures which give rise to the great arteries of the neck and head. They are ventral to the dorsal aorta and arise from the aortic sac.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9aeeaefabc8046dfa0c43fcd35211902x1280x1431.JPEG\" alt=\"Pearl Image\"><p>The following table shows various arterial structures derived from the aortic arches:<strong>&nbsp;</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Aortic arches</strong></p>\n</td>\n<td>\n<p><strong>Arterial Structures</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>First aortic arches</p>\n</td>\n<td>\n<p>Part of maxillary arteries bilaterally</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Second aortic arches</p>\n</td>\n<td>\n<p>Stapedial and hyoid arteries bilaterally</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Third aortic arches</p>\n</td>\n<td>\n<p>Common carotid arteries and proximal portion of internal carotid arteries bilaterally</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fourth aortic arches</p>\n</td>\n<td>\n<p>Right: Proximal portion of the right subclavian artery</p>\n<p>Left: aortic arch</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fifth aortic arch</p>\n</td>\n<td>\n<p>Regress completely</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sixth aortic arch</p>\n</td>\n<td>\n<p>Right: proximal right pulmonary artery</p>\n<p>Left: proximal left pulmonary artery, ductus arteriosus</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5360",
      "difficulty": "medium"
    },
    {
      "text": "The WHO defines disabling hearing loss in adults as a hearing loss of more than:",
      "choices": [
        {
          "id": 1,
          "text": "60 dB"
        },
        {
          "id": 2,
          "text": "45 dB"
        },
        {
          "id": 3,
          "text": "35 dB"
        },
        {
          "id": 4,
          "text": "25 dB"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>According to WHO, <strong>disabling hearing loss</strong> refers to hearing loss<strong> greater than 35 dB</strong> in the better hearing ear in <strong>adults</strong>.</p>\n<p>WHO grades of hearing loss:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Grade of hearing loss range</strong></td>\n<td><strong>Range of hearing loss</strong></td>\n</tr>\n<tr>\n<td>0: No impairment</td>\n<td>&lt; 20 dB</td>\n</tr>\n<tr>\n<td>1: Mild</td>\n<td>20 - 34 dB</td>\n</tr>\n<tr>\n<td>2: Moderate</td>\n<td>35 - 49 dB</td>\n</tr>\n<tr>\n<td>3: Moderately Severe</td>\n<td>50 - 64 dB</td>\n</tr>\n<tr>\n<td>4: Severe</td>\n<td>65 - 79 dB</td>\n</tr>\n<tr>\n<td>5: Profound</td>\n<td>&gt;80 dB</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><p><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;World Hearing Day 2023 observed on March 3, will highlight the importance of integrating ear and hearing care within primary care, as an essential component of universal health coverage. The theme for the this year's campaign is \\&quot;Ear and hearing care for all, let’s make it a reality\\&quot;&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:829,&quot;3&quot;:{&quot;1&quot;:0},&quot;5&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;6&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;11&quot;:4,&quot;12&quot;:0}\"><strong>World Hearing Day 2023</strong> observed on March 3, will highlight the importance of integrating ear and hearing care within primary care, as an essential component of universal health coverage. The theme for the this year's campaign is \"Ear and hearing care for all, let’s make it a reality\"</span></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6807",
      "difficulty": "hard"
    },
    {
      "text": "A 65-year-old man with a dragging sensation in his abdomen is found to have massive splenomegaly. The peripheral blood smear findings are as follows. Which of the following markers would you test to confirm the diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "CD65"
        },
        {
          "id": 2,
          "text": "CD207"
        },
        {
          "id": 3,
          "text": "CD1a"
        },
        {
          "id": 4,
          "text": "CD103"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The clinical features and peripheral smear showing fine circumferential cytoplasmic <strong>hairy projections</strong> point towards the diagnosis of <strong>hairy cell leukaemia</strong>.</p>\n<p>It's a rare but distinctive neoplasm of the B cells where splenomegaly is often the only abnormal finding. Pancytopenia from marrow involvement and sequestration of cells in the enlarged spleen is seen in half the cases and infections are seen in one-third of the affected patients. </p>\n<p><strong>CD103</strong> must be tested among the markers to confirm <strong>hairy cell leukaemia</strong>.</p>\n<p><strong>Hairy-cell</strong> leukaemias typically express the following markers:</p>\n<ul>\n<li>Pan B-cell markers CD<strong>19</strong>, CD<strong>20</strong>,<strong> surface Ig</strong> (usually IgG) </li>\n<li>CD<strong>11c</strong></li>\n<li>CD<strong>25</strong></li>\n<li>CD<strong>103</strong></li>\n<li><strong>Annexin A1</strong>.</li>\n</ul>\n<p><strong>Annexin A1</strong> is the most <strong>specific</strong> and <strong>sensitive</strong> marker.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/f754dc7934424d90a3a339359c9209de.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0193",
      "difficulty": "medium"
    },
    {
      "text": "Mutation in which of the following genes causes Wilson's disease?",
      "choices": [
        {
          "id": 1,
          "text": "ADP 7B"
        },
        {
          "id": 2,
          "text": "ADP 7A"
        },
        {
          "id": 3,
          "text": "ATP 7A"
        },
        {
          "id": 4,
          "text": "ATP 7B"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<div class=\"page\" title=\"Page 868\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Wilson's disease</strong>&nbsp;is caused due to a <strong>loss-of-function</strong> mutation in the&nbsp;<strong>ATP7B </strong>gene. It&nbsp;an <strong>autosomal recessive</strong> condition.</p>\n<div class=\"page\" title=\"Page 856\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The ATP7B gene is located on <strong>chromosome&nbsp;13q</strong>.&nbsp;The gene encodes a copper transporting ATPase (ATP7B) which has 2 functions:</p>\n<ul>\n<li aria-level=\"1\">Maintains copper in bound form by binding copper to apoceruloplasmin</li>\n<li aria-level=\"1\">Helps excrete free copper in bile.</li>\n</ul>\n<p>The resulting <strong>ATP7B deficiency</strong> leads to&nbsp;reduced bound copper and impaired free copper excretion. This causes <strong>excess deposition </strong>of<strong> free copper</strong> in the tissues, particularly in the liver, brain and eye.</p>\n</div>\n</div>\n</div>\n</div>\n<div class=\"page\" title=\"Page 720\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Menkes disease</strong> is an <strong>X-linked recessive</strong> condition leading to impaired absorption of copper and subsequent <strong>copper deficiency.</strong> Here, the mutation is in the<strong><em>&nbsp;</em>ATP7A </strong>gene.</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2743",
      "difficulty": "medium"
    },
    {
      "text": "A 17-year-old girl presented with primary amenorrhoea. On physical examination, her breast and areola are enlarged without separation of their contours. What is the sexual maturity rating in this girl?",
      "choices": [
        {
          "id": 1,
          "text": "SMR stage 1"
        },
        {
          "id": 2,
          "text": "SMR stage 2"
        },
        {
          "id": 3,
          "text": "SMR stage 3"
        },
        {
          "id": 4,
          "text": "SMR stage 4"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Breast and areola enlargement without the separation of the&nbsp;contour is seen in sexual&nbsp;maturity rating (<strong>SMR</strong>)<strong> stage 3</strong>.</p>\n<table><caption><span>Sexual Maturity Rating Stages in Females</span></caption>\n<tbody>\n<tr>\n<td>SMR Stage</td>\n<td>PUBIC HAIR</td>\n<td>BREASTS</td>\n</tr>\n<tr>\n<td>1</td>\n<td>Preadolescent</td>\n<td>Preadolescent</td>\n</tr>\n<tr>\n<td>2</td>\n<td>\n<p>sparse, lightly pigmented, straight,</p>\n<p>medial border of labia</p>\n</td>\n<td>\n<p>Breast and papilla elevated as a&nbsp;small mound;</p>\n<p>diameter of areola increased</p>\n</td>\n</tr>\n<tr>\n<td>3</td>\n<td>\n<p>Darker, beginning to curl,</p>\n<p>increased amount</p>\n</td>\n<td>\n<p>Breast and areola enlarged;</p>\n<p>no contour separation</p>\n</td>\n</tr>\n<tr>\n<td>4</td>\n<td>\n<p>Coarse, curly, abundant,</p>\n<p>but less than that&nbsp;in adults</p>\n</td>\n<td>Areola and papilla form a&nbsp;<strong>secondary mound</strong></td>\n</tr>\n<tr>\n<td>5</td>\n<td>\n<p>Adult feminine triangle,</p>\n<p>spread to the&nbsp;medial surface of thighs</p>\n</td>\n<td>\n<p>Mature, nipple projects,</p>\n<p>areola part of a general breast contour</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<table><caption><span>Sexual Maturity Rating Stages in Males</span></caption>\n<tbody>\n<tr>\n<td>SMR STAGE</td>\n<td>&nbsp;PUBIC HAIR</td>\n<td>PENIS</td>\n<td>TESTES</td>\n</tr>\n<tr>\n<td>1</td>\n<td>None</td>\n<td>Preadolescent</td>\n<td>Preadolescent</td>\n</tr>\n<tr>\n<td>2</td>\n<td>\n<p>Scanty, long,</p>\n<p>slightly pigmented</p>\n</td>\n<td>Minimal change/enlargement</td>\n<td>\n<p>Enlarged scrotum,</p>\n<p>pink, texture altered</p>\n</td>\n</tr>\n<tr>\n<td>3</td>\n<td>\n<p>Darker, starting to curl,</p>\n<p>small amount</p>\n</td>\n<td>Lengthens</td>\n<td>Larger</td>\n</tr>\n<tr>\n<td>4</td>\n<td>\n<p>Resembles adult-type but less quantity,</p>\n<p>coarse, curly</p>\n</td>\n<td>\n<p>Larger;</p>\n<p>glans and breadth increase in size</p>\n</td>\n<td>\n<p>Larger,</p>\n<p>scrotum dark</p>\n</td>\n</tr>\n<tr>\n<td>5</td>\n<td>\n<p>Adult distribution,</p>\n<p>spread to the&nbsp;medial surface of thighs</p>\n</td>\n<td>Adult size</td>\n<td>Adult size&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1587",
      "difficulty": "medium"
    },
    {
      "text": "Half-life which pair is correct?",
      "choices": [
        {
          "id": 1,
          "text": "Iodine131- 80 days"
        },
        {
          "id": 2,
          "text": "Iodine125- 50 days"
        },
        {
          "id": 3,
          "text": "Iodine123- 13 hours"
        },
        {
          "id": 4,
          "text": "Iodine124- 12 days"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Half life of Iodine<sup>123 </sup>&nbsp;is 13 hours.</p>\n<p>Half life of Iodine<sup>124</sup> is 4.18 days</p>\n<p>Half life of Iodine<sup>125</sup> is 59 days</p><hr><h3>Related Pearl: Half life of radio isotopes</h3><table>\n<tbody>\n<tr>\n<td><strong>Radioisotope</strong></td>\n<td><strong>Half-life</strong></td>\n</tr>\n<tr>\n<td>Cobalt 60</td>\n<td>5.2 years</td>\n</tr>\n<tr>\n<td>Iridium 192</td>\n<td>74 days</td>\n</tr>\n<tr>\n<td>Iodine 131</td>\n<td>8 days</td>\n</tr>\n<tr>\n<td>Iodine 125</td>\n<td>60 days</td>\n</tr>\n<tr>\n<td>Iodine 123</td>\n<td>13 hours</td>\n</tr>\n<tr>\n<td>Iodine 132</td>\n<td>3 hours&nbsp;</td>\n</tr>\n<tr>\n<td>Cesium 137</td>\n<td>30 years</td>\n</tr>\n<tr>\n<td>Technetium 99m</td>\n<td>6 Hours</td>\n</tr>\n<tr>\n<td>18 FDG</td>\n<td>110 minutes</td>\n</tr>\n<tr>\n<td>Radon 222</td>\n<td>3.8 days</td>\n</tr>\n<tr>\n<td>Radium 226</td>\n<td>1600 years</td>\n</tr>\n<tr>\n<td>Strontium-89</td>\n<td>50.5 days</td>\n</tr>\n<tr>\n<td>Strontium- 90</td>\n<td>28 years</td>\n</tr>\n<tr>\n<td>Phosphorus 32</td>\n<td>14 days</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5554",
      "difficulty": "medium"
    },
    {
      "text": "Pin index given for oxygen gas under pin index system is _________",
      "choices": [
        {
          "id": 1,
          "text": "2,5"
        },
        {
          "id": 2,
          "text": "1,5"
        },
        {
          "id": 3,
          "text": "1,6"
        },
        {
          "id": 4,
          "text": "3,5"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Pin index system for oxygen gas is 2, 5.</p>\n<p>Pin index safety system(PISS) is a safety measure to prevent incorrect cylinder attachment.</p><hr><h3>Related Pearl: Pin index safety system (PISS):</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b4558d677c5c41dbbe34006bd919cabdx1280x2768.51904090268.JPEG\" alt=\"Pearl Image\"><p>Note:</p>\n<ul>\n<li>Mixtures of CO<sub>2</sub> and O<sub>2</sub>&nbsp;with more than 7% CO<sub>2</sub>: <strong>1,6</strong><sup id=\"cite_ref-pin_code_2-2\" class=\"reference\"></sup></li>\n<li>Mixtures of&nbsp;CO<sub>2</sub> and O<sub>2</sub>&nbsp;with less than 7% CO<sub>2</sub>: <strong>2,6</strong><sup id=\"cite_ref-pin_code_2-3\" class=\"reference\"></sup></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6385",
      "difficulty": "easy"
    },
    {
      "text": "A child was able to count 4 pennies but was unable to name 4 colors. The probable age of the child is ______.",
      "choices": [
        {
          "id": 1,
          "text": "3 years"
        },
        {
          "id": 2,
          "text": "4 years"
        },
        {
          "id": 3,
          "text": "5 years"
        },
        {
          "id": 4,
          "text": "6 years"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>A 4-year-old child can count 4 pennies but cannot name 4 colours. A child can name 4 colours at <strong>5 years</strong> of age.</p>\n<p>Note:</p>\n<p>An easy way to remember this:</p>\n<ul>\n<li>No. of <strong>objects</strong> counted = <strong>age</strong></li>\n<li>No. of <strong>colours</strong> identified = <strong>age - 1</strong></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1338",
      "difficulty": "medium"
    },
    {
      "text": "As the intern assisting in the labor room, you are tasked with administering Vitamin K  to the term newborns with no complications. Which of the following dose and route would you use for administration?",
      "choices": [
        {
          "id": 1,
          "text": "0.5 - 1 mg IM"
        },
        {
          "id": 2,
          "text": "5 - 10 mg IV"
        },
        {
          "id": 3,
          "text": "1 -  5 mg IV"
        },
        {
          "id": 4,
          "text": "0.1 - 0.5 mg IM"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>All newborn infants are to be administered <strong>vitamin</strong> <strong>K</strong> at a dose of <strong>0.5–1 mg intramuscularly,</strong> to prevent hemorrhagic disease of the newborn (HDN).</p>\n<p>However, for newborns with <strong>vitamin</strong> <strong>K deficiency,</strong> the dose of vitamin K administered is <strong>1–5 mg intravenously.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9628",
      "difficulty": "easy"
    },
    {
      "text": "A female patient in normal labor is being administered care with active management of the third stage of labor. What is the dose of misoprostol that you would administer orally for the prevention of postpartum hemorrhage (PPH)?",
      "choices": [
        {
          "id": 1,
          "text": "300  micrograms"
        },
        {
          "id": 2,
          "text": "400  micrograms"
        },
        {
          "id": 3,
          "text": "600  micrograms"
        },
        {
          "id": 4,
          "text": "800  micrograms"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>600 micrograms</strong> of misoprostol <strong>administered orally</strong> <strong>at delivery</strong> is effective for the <strong>prevention</strong> of postpartum hemorrhage (PPH). &nbsp;</p>\n<p>Misoprostol is a synthetic prostaglandin E 1 analog that has been used for the prevention and treatment of uterine atony and PPH.&nbsp; &nbsp;</p>\n<p>Although contrasting evidence about its effectiveness is present, it is to be used at a dose of 600 micrograms when used orally.</p><hr><h3>Related Pearl: Uses of Misoprostol</h3><table>\n<tbody>\n<tr>\n<td><strong>INDICATIONS</strong></td>\n<td><strong>PRIMARY DOSE OF MISOPROSTOL</strong></td>\n<td><strong>REMARKS</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>MEDICAL TERMINATION OF PREGNANCY</strong></p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Combined Regimen(recommended):<br />Upto 12 weeks of gestation-800mcg vaginally, buccally or sublingually.<br /><br /></p>\n<p>Beyond 12 weeks of gestation-400mcg&nbsp;vaginally, buccally or sublingually every 3 hours<br /><br /><br /></p>\n<p>Misoprostol only regimen:<br />Upto 12 weeks-800mcg&nbsp;vaginally, buccally or sublingually<br /><br />Beyond 12 weeks-400mcg&nbsp;vaginally, bucally or sublingually every 3 hours<br /><br /></p>\n</td>\n<td>\n<p>Ideally used 1-2 days after 200mg of Mifepristone in the combined regimen.</p>\n<p><br />The mucosal route of administration is preferred over the oral route of administration.</p>\n<p><br />These doses also apply for incomplete and missed abortion.<br /><br /></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>SURGICAL ABORTION</strong></p>\n<p>12-14weeks- both medical and surgical methods can be done</p>\n<p>&gt;14weeks-surgical method&nbsp;</p>\n</td>\n<td>Cervical preparation: 400mcg vaginally/ sublingually</td>\n<td>\n<p>Another method: Oral Mifepristone 200mg 24-48 hours before the procedure</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td><strong>PPH Prophylaxis</strong></td>\n<td>\n<p>800mcg sublingual single dose OR 600mcg orally/ sublingually/rectally</p>\n<p>single dose&nbsp;for PPH secondary prevention (approx &gt;350ml blood loss)</p>\n</td>\n<td rowspan=\"2\">&nbsp;Where oxytocin is not available or storage conditions are inadequate</td>\n</tr>\n<tr>\n<td><strong>PPH treatment</strong></td>\n<td>800 mcg sublingually single dose</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6337",
      "difficulty": "medium"
    },
    {
      "text": "Size of the laryngeal mask airway that can be used in a child weighing 15 kgs is _________",
      "choices": [
        {
          "id": 1,
          "text": "1"
        },
        {
          "id": 2,
          "text": "1.5"
        },
        {
          "id": 3,
          "text": "2"
        },
        {
          "id": 4,
          "text": "2.5"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Size 2</strong> laryngeal mask airway can be used in a child weighing 15 kgs.</p>\n<p>Laryngeal mask airway is a supraglottic airway device which is placed in the hypopharynx and protects the larynx from laryngeal secretions. The largest possible size is chosen so as to ensure an airtight seal.</p>\n<p>Different sizes of the laryngeal mask airway</p>\n<table>\n<tbody>\n<tr>\n<td>Mask size</td>\n<td>Patient Size</td>\n<td>Weight (kg)</td>\n<td>Cuff&nbsp;Volume (mL)</td>\n</tr>\n<tr>\n<td>1</td>\n<td>Infant</td>\n<td>&lt;5</td>\n<td>2-4</td>\n</tr>\n<tr>\n<td>1.5</td>\n<td>Infant</td>\n<td>5-10</td>\n<td>upto 7</td>\n</tr>\n<tr>\n<td>2</td>\n<td>Child</td>\n<td>10-20</td>\n<td>upto 10</td>\n</tr>\n<tr>\n<td>2.5</td>\n<td>Child</td>\n<td>20-30</td>\n<td>upto 14</td>\n</tr>\n<tr>\n<td>3</td>\n<td>Small Adult</td>\n<td>30-50</td>\n<td>upto 20</td>\n</tr>\n<tr>\n<td>4</td>\n<td>Normal adult (women)</td>\n<td>50-70</td>\n<td>upto 30</td>\n</tr>\n<tr>\n<td>5</td>\n<td>Normal adult</td>\n<td>&gt;70</td>\n<td>30-40</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4419",
      "difficulty": "medium"
    },
    {
      "text": "To eradicate measles, the children under 1 year of age to be vaccinated is at least ______ %",
      "choices": [
        {
          "id": 1,
          "text": "72"
        },
        {
          "id": 2,
          "text": "87"
        },
        {
          "id": 3,
          "text": "81"
        },
        {
          "id": 4,
          "text": "96"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>To eradicate measles, at least 96% of the children under 1 year of age, need to be vaccinated.</p>\n<p>Factors in favor of measles eradication are that only 2 doses are needed and a more heat stable measles vaccine has now been developed.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5697",
      "difficulty": "medium"
    },
    {
      "text": "The weight of a baby on day 10 of life is normally:",
      "choices": [
        {
          "id": 1,
          "text": "20% less than birth weight"
        },
        {
          "id": 2,
          "text": "Same as the birth weight"
        },
        {
          "id": 3,
          "text": "1.2 times the birth weight"
        },
        {
          "id": 4,
          "text": "1.5 times the birthweight"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The newborn baby <strong>loses weight in the first few days after birth</strong>, and it <strong>regains its birth weight by 7-10 days</strong>. &nbsp;</p>\n<p>Hence, the weight on day 10 of life would be the same as birth weight. &nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6326",
      "difficulty": "medium"
    },
    {
      "text": "CT number of lung parenchyma in inspiration is _______.",
      "choices": [
        {
          "id": 1,
          "text": "0 HU"
        },
        {
          "id": 2,
          "text": "-100 HU"
        },
        {
          "id": 3,
          "text": "-1000 HU"
        },
        {
          "id": 4,
          "text": "+1000 HU"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>CT number of lung parenchyma in inspiration is -1000 HU. Lung parenchyma in inspiration has a CT number similar to air.</p>\n<p>On CT, each image consists of a matrix of data points (pixels) that are assigned a number that represents the X-ray attenuation(&mu;) at that point in the body.</p>\n<p>CT number is a scaled version of &mu; that is normalised to the X-ray attenuation of <strong>water</strong> (&mu;<sub>W</sub>) CT = 1000 &times; (&mu;/&mu;W &minus; 1).</p>\n<p>The resulting numbers are called &lsquo;Hounsfield units&rsquo;(HU).</p>\n<p>Due to this normalisation, and <strong>water is assigned 0 HU</strong> and air is assigned a CT number of &minus;1000 HU.</p>\n<p>The CT numbers of</p>\n<ul>\n<li>Water = 0 HU</li>\n<li>Solid soft tissues = 0 HU</li>\n<li>Air = -1000 HU</li>\n<li>Lungs = -1000 HU</li>\n<li>Dense cortical bone = +1000 HU</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4155",
      "difficulty": "medium"
    },
    {
      "text": "What is the range of correlation coefficient?",
      "choices": [
        {
          "id": 1,
          "text": "-1 to +1"
        },
        {
          "id": 2,
          "text": "0 to +1"
        },
        {
          "id": 3,
          "text": "-1 to 0"
        },
        {
          "id": 4,
          "text": "0 to +2"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The range of correlation coefficient is -1 to +1.</p><hr><h3>Related Pearl: Correlation</h3><p><strong>Correlation</strong> expresses the <strong>strength</strong> and <strong>direction</strong> of the relationship between two variables in terms of a <strong>correlation coefficient</strong>. It is represented by&nbsp;<strong>r</strong>.</p>\n<ul>\n<li>Values of r vary from <strong>-1</strong> (perfect negative correlation) to <strong>+1</strong> (perfect positive correlation).</li>\n<li>Value (size) of the coefficient: Indicates the strength of relationship</li>\n<li>Sign of the coefficient: Indicates direction of relationship</li>\n</ul>\n<p>Coefficients between &plusmn;0.5 and 1 are regarded as strong whereas those between &plusmn;0.5 and 0 are regarded as weak.</p>\n<p>The data is plotted in a <strong>scattergram</strong> as shown in the examples given below</p>\n<p>Examples:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/333f39128051444e8f62260f161639ebx1280x2998.JPEG\" alt=\"Pearl Image\"><p><strong>Types of correlation coefficients</strong></p>\n<ol>\n<li>Pearson coefficient</li>\n<li>Spearman coefficient</li>\n</ol><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/69ce1962b6b64f638b91fe579a829ac4x1280x1675.JPEG\" alt=\"Pearl Image\"><p><strong>Coefficient of Determination (CD) =&nbsp;&nbsp;r<sup>2</sup></strong></p>\n<p>It is simply the percentage variability in one factor due to change in another variable.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5539",
      "difficulty": "easy"
    },
    {
      "text": "How long should a child be isolated after being diagnosed with bacterial meningitis to prevent further transmission?",
      "choices": [
        {
          "id": 1,
          "text": "Till 24 hours after starting antibiotics"
        },
        {
          "id": 2,
          "text": "Till cultures become negative"
        },
        {
          "id": 3,
          "text": "Till antibiotic course is complete"
        },
        {
          "id": 4,
          "text": "Till 12 hours after admission"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Isolation of the child is recommended<strong>&nbsp;until 24 hrs after the initiation of effective therapy&nbsp;</strong>after being diagnosed with acute bacterial meningitis to prevent further transmission.</p>\n<p><strong>Droplet precautions</strong> are recommended for patients with&nbsp;<strong>Neisseria meningitides&nbsp;</strong>and <strong>Haemophilus influenzae<em>&nbsp;</em>type b (Hib) meningitis</strong> until they have received 24 hours of effective therapy. Patients should be in private rooms, and hospital personnel should wear a face mask when they are within 3 feet (1 meter) of the patient.</p>\n<p>The child with meningitis shows nonspecific symptoms like <strong>fever,</strong> anorexia, <strong>poor feeding</strong>, headache, myalgia, <strong>hypotension</strong>,&nbsp;petechia, purpura, or a <strong>rash</strong>. Meningial irritation is indicated by&nbsp;<strong>nuchal rigidity</strong>, back pain, and&nbsp;<strong>Kernig, and Brudzinski signs </strong>(usually not seen in infants). <strong>Seizures</strong> and <strong>altered mental status</strong> may be present.&nbsp;</p>\n<p>The recommended <strong>empirical antibiotic</strong> regimen in a suspected case of meningitis outside the neonatal period is <strong>vancomycin</strong> combined with a <strong>third-generation cephalosporin</strong>. Patients <strong>allergic to penicillin</strong> or cephalosporin can be treated with <strong>meropenem, fluoroquinolones</strong>, or <strong>chloramphenicol</strong>.&nbsp;</p>\n<p><strong>Chemoprophylaxis&nbsp;</strong>with<strong> rifampicin/ceftriaxone/ciprofloxacin</strong> is recommended for all close contacts with <strong>meningococcal</strong> meningitis regardless of age or immunization status.&nbsp;<strong>Rifampicin prophylaxis</strong> should be given to all <strong>household contacts</strong> of patients with invasive disease caused by<strong> Haemophilus influenzae type b</strong>, if an <strong>immunocompromised child</strong> of any age resides in the household or close family member <strong>younger than 48 months</strong> has<strong> not</strong> been<strong> fully immunized</strong>.&nbsp;</p><hr><h3>Related Pearl: Acute bacterial meningitis - causes and empirical treatment</h3><table>\n<tbody>\n<tr>\n<td><strong>Patient Group</strong></td>\n<td><strong>Bacterial Pathogen</strong></td>\n<td><strong>Empirical Therapy</strong></td>\n</tr>\n<tr>\n<td>Age&lt;1 month</td>\n<td>\n<p><em>E. coli</em></p>\n<p>Group B Streptococci</p>\n<p>Enterobacteriacea</p>\n<p><em>Listeria monocytogenes</em></p>\n</td>\n<td>3rd generation Cephalosporin+<br />Ampicillin</td>\n</tr>\n<tr>\n<td>1 month - 2 years</td>\n<td>\n<p><em>E. coli</em></p>\n<p>Group B Streptococci</p>\n<p><em>H. influenza</em></p>\n<p><em>S. pneumonia</em></p>\n<p><em>N. meningitidis</em></p>\n</td>\n<td>3rd generation Cephalosporin+<br />Ampicillin+<br />Vancomycin (if PRSP suspected)</td>\n</tr>\n<tr>\n<td>2 - 50 years and no risk factors for Listeria</td>\n<td><em>S. pneumoniae</em><br /><em>N. meningitidis</em><br /><br /></td>\n<td>\n<p>3rd generation cephalosporin+<br />Vancomycin</p>\n</td>\n</tr>\n<tr>\n<td>Age &gt; 50 yrs and/or risk factors for Listeria</td>\n<td><em>S. pneumoniae</em><br /><em>N. meningitidis</em><br /><em>L. monocytogenes</em><br />Group B Streptococci</td>\n<td>\n<p>3rd generation cephalosporin+<br />Vancomycin+<br />Ampicillin</p>\n</td>\n</tr>\n<tr>\n<td>Post-craniotomy/Head trauma/CSF Rhinorrhea</td>\n<td>Gram negative bacilli</td>\n<td>\n<p>Ceftazidime+<br />Vancomycin</p>\n</td>\n</tr>\n<tr>\n<td>Post-shunt surgery/ Ommaya reservoir</td>\n<td>\n<p><em>S. aureus</em><br />Coagulase-negative staphylococci</p>\n</td>\n<td>Ceftazidime+<br />Vancomycin</td>\n</tr>\n<tr>\n<td>Immunocompromised state </td>\n<td>\n<p><em> S. pneumoniae                    </em></p>\n<p><em>N. meningitidis                    </em></p>\n<p><em>L. monocytogenes       </em></p>\n<p>Gram negative bacilli </p>\n</td>\n<td>\n<p>Vancomycin+                      Ampicillin+                         Cefepime                           </p>\n<p>                   OR </p>\n<p>Vancomycin+                      Meropenem      </p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*PRSP= penicillin-resistant S pneumoniae </p><hr><h3>Related Pearl: CSF findings in meningitis</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Glucose&nbsp;</strong><br /><strong>(mg/dL)</strong></td>\n<td><strong>Protein</strong><br /><strong>(mg/dL)</strong></td>\n<td><strong>WBC (per&nbsp;&mu;L)</strong></td>\n</tr>\n<tr>\n<td><strong>Normal</strong></td>\n<td>40-85</td>\n<td>15-45</td>\n<td>\n<p>&lt;5</p>\n<p>60-70% lymphocytes, &le;30% monocytes / macrophages</p>\n</td>\n</tr>\n<tr>\n<td><strong>Bacterial</strong></td>\n<td>&lt;40</td>\n<td>&gt;100</td>\n<td>\n<p>&gt;1000</p>\n<p>&uarr;&uarr;PMNs (&ge;80%)</p>\n</td>\n</tr>\n<tr>\n<td><strong>Viral</strong></td>\n<td>Normal</td>\n<td>20-80</td>\n<td>\n<p>25-500</p>\n<p>Predominantly lymphocytes</p>\n</td>\n</tr>\n<tr>\n<td><strong>Tuberculous</strong></td>\n<td>&lt;50 <br />in 75% cases</td>\n<td>100-200</td>\n<td>\n<p>25-100</p>\n<p>Predominantly lymphocytes</p>\n</td>\n</tr>\n<tr>\n<td><strong>Fungal</strong></td>\n<td>&darr; to normal</td>\n<td>150-300</td>\n<td>\n<p>40-600</p>\n<p>Lymphocytes or PMNs, depending on specific organism</p>\n</td>\n</tr>\n<tr>\n<td><strong>Parasitic</strong></td>\n<td>Normal</td>\n<td>50-200&nbsp;</td>\n<td>\n<p>150-2000</p>\n<p>&uarr;&uarr; Eosinophils (&ge;50%)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5246",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is used in the treatment of late cardiovascular syphilis?",
      "choices": [
        {
          "id": 1,
          "text": "Benzathine penicillin 2.4 million units weekly for three weeks"
        },
        {
          "id": 2,
          "text": "Benzathine penicillin 2.4 million units as single dose"
        },
        {
          "id": 3,
          "text": "Benzathine penicillin 12-24 million units for 21 days"
        },
        {
          "id": 4,
          "text": "Tetracycline 2g daily"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Benzathine penicillin 2.4 million</strong> units weekly for <strong>three weeks</strong> is the treatment of <strong>late cardiovascular</strong> syphilis.</p>\n<p>The treatment of syphilis is based on the CDC&rsquo;s 2015 guidelines:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Stage of Syphilis</strong></td>\n<td><strong>Patients without Penicillin Allergy</strong></td>\n<td><strong>Patients with Confirmed Penicillin Allergy</strong></td>\n</tr>\n<tr>\n<td>Primary, Secondary and early latent</td>\n<td>\n<p>CSF Normal or not examined: Penicillin G benzathine&nbsp; &nbsp; &nbsp;(single dose 2.4mU IM)&nbsp;</p>\n<p>CSF Abnormal: Treat as Neurosyphilis</p>\n</td>\n<td>\n<p>CSF normal or not examined: Tetracycline HCl (500 mg PO qid)</p>\n<p>OR</p>\n<p>Doxycycline(100 mg PO bid) for 2 weeks&nbsp;CSF abnormal: Treat as neurosyphilis</p>\n</td>\n</tr>\n<tr>\n<td>Late latent (or latent of uncertain duration), <strong>Cardiovascular</strong> or benign tertiary</td>\n<td>\n<p>CSF Normal or not examined: Penicillin G benzathine&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 2.4 mU IM weekly for 3 weeks &nbsp;</p>\n<p>CSF Abnormal: Treat as Neurosyphilis</p>\n</td>\n<td>\n<p>CSF normal and patient not infected with HIV: Tetracycline HCl (500 mg PO qid)</p>\n<p>OR</p>\n<p>Doxycycline (100 mg PO bid) for 4 weeks&nbsp;</p>\n<p>CSF normal and patient infected with HIV: Desensitization and treatment with penicillin if compliance cannot be ensured&nbsp;</p>\n<p>CSF abnormal: Treat as neurosyphilis</p>\n</td>\n</tr>\n<tr>\n<td>Neurosyphilis (asymptomatic or symptomatic)</td>\n<td>\n<p>Aqueous crystalline penicillin G (18-24 mU/d IV),&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; given as 3-4mU q4h or continuous infusion for 10-14 days.</p>\n<p>OR</p>\n<p>Aqueous procaine penicillin G (2.4mU/d IM)&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;+&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Oral probenecid(500mg qid), both for 10-14 days.</p>\n</td>\n<td>Desensitization and treatment with penicillin</td>\n</tr>\n<tr>\n<td>Syphilis in Pregnancy</td>\n<td>According to stage</td>\n<td>Desensitization and treatment with penicillin&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>Note:</strong></p>\n<p class=\"p1\">mU is a million units, not milli-units.</p><hr><h3>Related Pearl: Stages of syphilis</h3><p><strong><strong>Primary syphilis:</strong></strong></p>\n<ul>\n<li aria-level=\"1\"><strong>Chancre</strong> - Painless, indurated, usually single. The chancre self heals in 1-4 months.</li>\n<li aria-level=\"1\">Lymphadenopathy - Painless, unilateral or bilateral, shotty and rubbery inguinal nodes</li>\n<li aria-level=\"1\"><strong>Dory flop sign</strong> - As the chancre is too hard to fold, it will flip over once the prepuce is retracted back.</li>\n</ul>\n<p><strong>Secondary syphilis:</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/45e19098c36e4e0ba69bdbc3358cbb5fx559x788.JPEG\" alt=\"Pearl Image\"><ul>\n<li aria-level=\"1\">A &amp; B: Generalized non-itchy rash with no vesicles present on the palm and sole. This is the most common lesion.</li>\n<li aria-level=\"1\">C &amp; D:<strong> Condyloma lata</strong>.</li>\n<li aria-level=\"1\">E:<strong> Moth-eaten non-scarring alopecia</strong></li>\n<li aria-level=\"1\">F: Mucous patches are flat erosions on the tongue that can coalesce to form<strong> snail track ulcers.</strong> These are the most infectious lesions.</li>\n<li aria-level=\"1\">G: Pigmentary plaques</li>\n<li aria-level=\"1\">H: Psoriasiform syphilitic lesions</li>\n<li aria-level=\"1\">Generalized diffuse non-tender lymphadenopathy</li>\n</ul>\n<p><strong>Tertiary syphilis:</strong></p>\n<ul>\n<li aria-level=\"1\"><strong>Gummatous syphilis</strong> are deep punched-out ulcers, with gum-like secretions on the floor</li>\n<li aria-level=\"1\"><strong>Pseudo-chancre redux</strong> is a gumma occurring at the site of a previously healed ulcer&nbsp;&nbsp;</li>\n<li aria-level=\"1\">CVS - Aortitis and aneurysm of the ascending aorta</li>\n<li aria-level=\"1\">CNS - General paresis of the insane and tabes dorsalis&nbsp;</li>\n</ul>\n<p><strong>Latent syphilis</strong> is the period between secondary and tertiary syphilis. In this period the patient is asymptomatic clinically and only serological evidence of the infection is present. It is classified into:</p>\n<ul>\n<li aria-level=\"1\">Early latent syphilis - Within 1 year of infection</li>\n<li aria-level=\"1\">Late latent syphilis - After 1 year of infection</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5294",
      "difficulty": "easy"
    },
    {
      "text": "Labour in a multipara is said to have prolonged latent phase when it goes beyond:",
      "choices": [
        {
          "id": 1,
          "text": "10 hours"
        },
        {
          "id": 2,
          "text": "12 hours"
        },
        {
          "id": 3,
          "text": "14 hours"
        },
        {
          "id": 4,
          "text": "24 hours"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The latent phase may be prolonged, which is defined as exceeding 20 hours in the nullipara and 14 hours in the multipara.</p>\n<p class=\"p1\">Abnormal Labor Patterns, Diagnostic Criteria, and Methods of Treatment :</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p class=\"p1\"><strong>Labor Pattern</strong></p>\n</td>\n<td>\n<p>&nbsp; &nbsp; <strong>&nbsp;Diagnostic criteria</strong></p>\n<p>&nbsp;<strong>Nullipara&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Multipara</strong></p>\n</td>\n<td>&nbsp;\n<p class=\"p1\">&nbsp;<strong>Preferred Treatment</strong></p>\n</td>\n<td>&nbsp;\n<p class=\"p1\"><strong>Exceptional Treatment</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\"p1\"><strong>Prolongation Disorder</strong></p>\n<p class=\"p2\">Prolonged latent phase</p>\n</td>\n<td>\n<p class=\"p1\">&gt; 20 hr&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<span class=\"s1\">&gt; </span><span class=\"s2\">14 hr</span></p>\n</td>\n<td>\n<p class=\"p1\">Bed rest</p>\n</td>\n<td>\n<p class=\"p1\">Oxytocin or cesarean delivery for urgent problems</p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\"p1\"><strong>Protraction Disorders</strong></p>\n<p class=\"p1\">Protracted active-phase dilation</p>\n<p class=\"p4\">Protracted descent</p>\n</td>\n<td>\n<p class=\"p1\">&nbsp;</p>\n<p class=\"p1\">&lt; l.2 cm/hr&nbsp; &nbsp; &nbsp; &nbsp;<span class=\"s1\">1.5 cm/hr</span></p>\n<p class=\"p1\">&lt; 1 cm/hr&nbsp; &nbsp; &nbsp; &nbsp;&nbsp;<span class=\"s1\">&lt; 2cm/hr</span></p>\n</td>\n<td>\n<p class=\"p1\">Expectant and&nbsp;support</p>\n</td>\n<td>\n<p class=\"p1\">Cesarean delivery for CPD</p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\"p1\"><strong>Arrest Disorders</strong></p>\n<p class=\"p2\">Prolonged deceleration phase</p>\n<p class=\"p2\">Secondary arrest of dilation</p>\n<p class=\"p2\">Arrest of descent</p>\n<p class=\"p9\">Failure of descent</p>\n</td>\n<td>\n<p class=\"p3\">&nbsp;</p>\n<p class=\"p1\">&gt; 3 hr&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&gt; 1 hr</p>\n<p class=\"p2\">&gt; 2 hr&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<span class=\"s1\">&gt; 2 hr</span></p>\n<p class=\"p3\">&gt; 1 hr&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&gt; 1 hr</p>\n<p class=\"p1\">No descent in deceleration phase or second stage</p>\n</td>\n<td>\n<p class=\"p1\">Evaluate for CPD:</p>\n<p class=\"p1\">CPD: cesarean</p>\n<p class=\"p1\">No CPD: oxytocin</p>\n</td>\n<td>\n<p class=\"p1\">Rest if exhausted</p>\n<p class=\"p2\">Cesarean delivery</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5413",
      "difficulty": "hard"
    },
    {
      "text": "Which transporter is required for the transport of iron into the enterocyte?",
      "choices": [
        {
          "id": 1,
          "text": "Ferroportin"
        },
        {
          "id": 2,
          "text": "Divalent metal transporter 1"
        },
        {
          "id": 3,
          "text": "Divalent metal transporter 2"
        },
        {
          "id": 4,
          "text": "Haptocorrin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>DMT1</strong>&nbsp;(divalent metal transporter 1) is required for the <strong>transport</strong> of <strong>iron</strong> into the <strong>enterocyte</strong>.</p>\n<p>Dietary iron is mostly in Fe<sup>3+</sup> (ferric state) and must be reduced to Fe<sup>2+</sup> (ferrous state) by ferrireductases.&nbsp;Fe2+ iron destined for circulation is transported from the cytoplasm across the basolateral enterocyte membrane by <strong>ferroportin 1.</strong></p>\n<p><strong>Hephaestin</strong> is an iron oxidase that converts Fe2+ to Fe3+</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4fd2556ab9a14b1196842c683c971ec7x1280x1098.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0286",
      "difficulty": "easy"
    },
    {
      "text": "What is the approximate time interval between HIV infection & manifestation of AIDS?",
      "choices": [
        {
          "id": 1,
          "text": "7.5 years"
        },
        {
          "id": 2,
          "text": "10 years"
        },
        {
          "id": 3,
          "text": "12 years"
        },
        {
          "id": 4,
          "text": "5 years"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The time interval between <strong>primary HIV</strong> infection and the <strong>manifestation</strong> of AIDS is <strong>10 years</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3427d6415f6a4fbaa5309f656fe49894x1280x1475.JPEG\" alt=\"Explanation Image\"><p>After exposure to the HIV virus, there occurs <strong>primary infection</strong> following an incubation period of <strong>2-4 weeks</strong>, which is usually symptomatic in more than 50% of cases, following <strong>3-6 weeks</strong> there is <strong>acute HIV syndrome</strong> due to wide dissemination of the virus, characterized by fever, sore throat, diarrhea, lymphadenopathy, and rash.</p>\n<p>This <strong>peak viremia drops</strong> as the <strong>immune response develops</strong>, to reach a <strong>plateau</strong> about <strong>3 months later</strong>.&nbsp;Following this there is a prolonged period of <strong>clinical latency</strong>, during which infected individuals are <strong>asymptomatic</strong>, lasting for a median of <strong>10 years</strong>.</p>\n<p>Following this period, <strong>chronic persistent infection</strong> develops which is the hallmark of HIV disease called&nbsp;<strong>Acquired immunodeficiency syndrome</strong> (AIDS).</p>\n<p>Long-term non-progressors: a small part of <strong>untreated HIV-infected</strong> people with <strong>CD4 counts</strong> within the <strong>reference range</strong> for <strong>&gt;10 years</strong>.&nbsp;</p>\n<p>Elite controllers: Some <strong>long-term non-progressors</strong> have <strong>undetectable viral loads</strong>.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4166",
      "difficulty": "easy"
    },
    {
      "text": "The time required for preoxygenation before tracheal intubation?",
      "choices": [
        {
          "id": 1,
          "text": "1 min"
        },
        {
          "id": 2,
          "text": "3 min"
        },
        {
          "id": 3,
          "text": "5-7 min"
        },
        {
          "id": 4,
          "text": "5 min"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Preoxygenation with <strong>tidal&nbsp;volume</strong> breathing of <strong>3 mins</strong> is required before tracheal intubation.</p>\n<p class=\"p1\"><span class=\"s1\">Preoxygenation or <strong>denitrogenation</strong> is the process of replacing nitrogen in the lungs with oxygen.</span></p>\n<p class=\"p1\"><span class=\"s1\">This delays the onset of critical hypoxia during the period of apnea by <strong>5-8 minutes.</strong></span></p>\n<p class=\"p1\"><span class=\"s1\">This lengthened apnea time provides an improved margin of safety while the anesthesiologist secures the airway and resumes ventilation. </span></p><p>This was a new question asked in AIIMS Nov-17 and hence a potential repeat in the upcoming sessions. The confusion might arise as there are two methods of preoxygenation. But 3 minutes is the most appropriate answer as explained.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9124",
      "difficulty": "easy"
    },
    {
      "text": "A 50-year-old man started experiencing chest pain and was rushed to a primary care facility at 10 AM. A diagnosis of acute severe MI was made. Due to the unavailability of PCI, he was taken to a tertiary center by 10:30 AM. By what time should PCI be performed in this patient at the latest?",
      "choices": [
        {
          "id": 1,
          "text": "11 AM"
        },
        {
          "id": 2,
          "text": "12 PM"
        },
        {
          "id": 3,
          "text": "11:30 AM"
        },
        {
          "id": 4,
          "text": "12:30 PM"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The <strong>door-to-balloon time</strong> for a patient arriving in a hospital that is <strong>not equipped </strong>to perform a PCI and is then transported to a hospital where PCI can be performed is&nbsp;<strong>120 min.</strong></p>\n<p>The door-to-balloon time is the time <strong>interval</strong> between the <strong>first medical contact</strong> and <strong>PCI</strong>.</p>\n<p>It is <strong>90 min or less</strong> for a patient arriving in a hospital<strong> equipped </strong>with PCI&nbsp;(ACC/AHA guidelines and MoHFW, India guidelines).<strong>&nbsp;</strong></p>\n<p>In patients who cannot receive PCI within 120 min of first medical contact, fibrinolysis is given. Fibrinolysis is only considered if the patient presents within 12 hours of symptom onset.</p>\n<p>Note: The European society of cardiology (ESC) recommends 60 min target time for&nbsp;patients presenting in a PCI-centre and 90 min maximum&nbsp;target time for PCI-mediated reperfusion.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2107",
      "difficulty": "medium"
    },
    {
      "text": "Grade 3 hemorrhagic shock the % of blood loss is:",
      "choices": [
        {
          "id": 1,
          "text": "<15%"
        },
        {
          "id": 2,
          "text": "15-30%"
        },
        {
          "id": 3,
          "text": "31-40%"
        },
        {
          "id": 4,
          "text": ">40%"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>When there is 31-40% Blood loss it is termed as Grade/Class 3 Hemorrhage.</p>\n<p>The physiological effects are divided into four classes, based on clinical signs, which are useful for estimating the percentage of acute blood loss. The clinical signs represent a continuum of ongoing hemorrhage and serve only to guide initial therapy.</p>\n<table>\n<tbody>\n<tr>\n<td>Parameter</td>\n<td>CLass I</td>\n<td>Class II(mild)</td>\n<td>\n<p>Class III</p>\n<p>(moderate)</p>\n</td>\n<td>\n<p>Class IV</p>\n<p>(severe)</p>\n</td>\n</tr>\n<tr>\n<td>Approximate blood loss</td>\n<td>&lt;15%</td>\n<td>15-30%</td>\n<td>31-40%</td>\n<td>&gt;40%</td>\n</tr>\n<tr>\n<td>Heart Rate</td>\n<td>Nomal</td>\n<td>Normal/Increased</td>\n<td>Increased</td>\n<td>Increased</td>\n</tr>\n<tr>\n<td>Blood Pressure</td>\n<td>Normal</td>\n<td>Normal</td>\n<td>Normal/Decreased</td>\n<td>Decreased</td>\n</tr>\n<tr>\n<td>Pulse Pressure</td>\n<td>Normal</td>\n<td>Decreased</td>\n<td>Decreased</td>\n<td>Decreased</td>\n</tr>\n<tr>\n<td>Respiratory Rate</td>\n<td>Normal</td>\n<td>Normal</td>\n<td>Normal/Increased</td>\n<td>Increased</td>\n</tr>\n<tr>\n<td>Urine Output</td>\n<td>Normal</td>\n<td>Normal</td>\n<td>Decreased</td>\n<td>Decreased</td>\n</tr>\n<tr>\n<td>Glasgow Coma Scale</td>\n<td>Normal</td>\n<td>Normal</td>\n<td>Decreased</td>\n<td>Decreased</td>\n</tr>\n<tr>\n<td>Need for blood products</td>\n<td>Monitor</td>\n<td>Possible</td>\n<td>Yes</td>\n<td>\n<p>Massive Transfusion Protocol</p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\"p1\"><strong>Base deficit<span class=\"s1\"> </span>  </strong></p>\n</td>\n<td>0 to –2 mEq/L</td>\n<td>–2 to –6 mEq/L </td>\n<td> –6 to –10 mEq/L</td>\n<td>–10 mEq/L or less </td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p><p>Base deficit has been added in the new ATLS 10th edition,2018</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5348",
      "difficulty": "easy"
    },
    {
      "text": "What is the incubation period of lymphogranuloma venereum?",
      "choices": [
        {
          "id": 1,
          "text": "1-5 days"
        },
        {
          "id": 2,
          "text": "7-10 days"
        },
        {
          "id": 3,
          "text": "10-30 days"
        },
        {
          "id": 4,
          "text": "30-60 days"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<div class=\"page\" title=\"Page 1603\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 1602\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The <strong>incubation period</strong> of <em><strong>Lymphogranuloma venereum</strong></em> ranges from <strong>10-30 days.</strong></p>\n<p><em>Chlamydia trachomatis</em> serovars L1, L2, and L3 cause lymphogranuloma venereum (LGV). The most common presentation is the<strong> inguinal syndrome</strong>, which is characterized by painful inguinal lymphadenopathy.</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Diseases with usual incubation period</h3><table>\n<tbody>\n<tr>\n<td><strong>Disease</strong></td>\n<td><strong>Incubation period(days)</strong></td>\n</tr>\n<tr>\n<td>Dengue</td>\n<td>5-8</td>\n</tr>\n<tr>\n<td>Typhoid</td>\n<td>10-14</td>\n</tr>\n<tr>\n<td>Herpes simplex</td>\n<td>5-8</td>\n</tr>\n<tr>\n<td>Enterovirus disease</td>\n<td>6-12</td>\n</tr>\n<tr>\n<td>Poliomyelitis</td>\n<td>5-20</td>\n</tr>\n<tr>\n<td>Measles</td>\n<td>9-12</td>\n</tr>\n<tr>\n<td>Smallpox</td>\n<td>12-14</td>\n</tr>\n<tr>\n<td>Chickenpox</td>\n<td>13-17</td>\n</tr>\n<tr>\n<td>Mumps</td>\n<td>16-20</td>\n</tr>\n<tr>\n<td>Rubella</td>\n<td>17-20</td>\n</tr>\n<tr>\n<td>Mononucleosis</td>\n<td>30-50</td>\n</tr>\n<tr>\n<td>Hepatitis A</td>\n<td>15-40</td>\n</tr>\n<tr>\n<td>Hepatitis B &amp; C</td>\n<td>50-150</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Comparison of Genital Ulcers</h3><table>\n<tbody>\n<tr>\n<td><span>&nbsp;</span></td>\n<td><span><strong>Genital herpes</strong></span></td>\n<td><span><strong>&nbsp;Syphilitic chancre (Hard chancre)</strong></span></td>\n<td><span><strong>Donovanosis/ granuloma inguinale</strong></span></td>\n<td><span><strong>Chancroid (soft chancre)</strong></span></td>\n<td><span><strong>LGV</strong></span></td>\n</tr>\n<tr>\n<td><span><strong>Incubation period</strong></span></td>\n<td><span>2-7 days</span></td>\n<td>\n<p><span>10-90 days&nbsp;</span></p>\n<p><span>Average: 21days</span></p>\n</td>\n<td><span>1-12 weeks</span></td>\n<td><span>1-14 days</span></td>\n<td><span>3 days - 6 weeks</span></td>\n</tr>\n<tr>\n<td><span><strong>Causative agent</strong></span></td>\n<td><span>HSV-2&gt;HSV-1</span></td>\n<td><em><span>Treponema pallidum</span></em></td>\n<td><em><span>Klebsiella granulomatis</span></em></td>\n<td><em><span>Hemophilus ducreyi</span></em></td>\n<td>\n<p><span><em>Chlamydia trachomatis</em></span><span>&nbsp;serovars L1,L2,L3</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Clinical presentation</strong></span></td>\n<td>\n<p><span>Cluster of vesicles on erythematous base.</span></p>\n<p><span> Painful and pruritic lymphadenopathy</span></p>\n</td>\n<td>\n<p><span>Single painless ulcer with a clean base and a firm raised border. </span></p>\n<p><span>Painless lymphadenopathy</span></p>\n</td>\n<td>\n<p><span>Painless papule or nodule erodes into beefy red granulomatous ulcer with rolled edges.</span></p>\n<p><span> No lymphadenopathy, pseudobubos are seen</span></p>\n</td>\n<td>\n<p><span>Painful ulcer (ducreyi makes you cry).</span></p>\n<p><span>Painful inguinal lymphadenopathy</span></p>\n</td>\n<td>\n<p><span>Painless genital ulcer.</span></p>\n<p><span>Painful inguinal lymphadenopathy</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Diagnosis&nbsp;</strong></span></td>\n<td><span>Tzanck preparation shows multinucleated giant cells, PCR</span></td>\n<td><span>Clinical diagnosis</span></td>\n<td><span>Donovan bodies on biopsy</span></td>\n<td><span>Clinical diagnosis</span></td>\n<td><span>Nucleic acid amplification tests</span></td>\n</tr>\n<tr>\n<td><span><strong>Treatment</strong></span></td>\n<td><span>Acyclovir/famcyclovir or valacyclovir</span></td>\n<td><span>Penicillin/Ceftriaxone</span></td>\n<td>\n<p><span>Azithromycin/</span><span>Doxycycline</span></p>\n</td>\n<td><span>Azithromycin/ceftriaxone</span></td>\n<td><span>&nbsp;Doxycycline</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3500",
      "difficulty": "medium"
    },
    {
      "text": "You are planning to administer radiotherapy to a 58-year-old woman diagnosed with carcinoma cervix. What is the dose to be administered at point B?",
      "choices": [
        {
          "id": 1,
          "text": "7000 cGY"
        },
        {
          "id": 2,
          "text": "6000 cGY"
        },
        {
          "id": 3,
          "text": "5000 cGy"
        },
        {
          "id": 4,
          "text": "8000 cGy"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In the treatment of carcinoma cervix, the dose to be administered at point B is&nbsp;<strong>6000 cGy</strong>.</p>\n<p>Radiotherapy in carcinoma cervix:</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Point A</strong></td>\n<td><strong>Point B</strong></td>\n</tr>\n<tr>\n<td><strong>Location</strong></td>\n<td>2cm above and 2cm lateral to external os</td>\n<td>2cm above and 5cm lateral to external os</td>\n</tr>\n<tr>\n<td><strong>Structure</strong></td>\n<td>Paracervical/Parametrial lymph node</td>\n<td>Obturator lymph node</td>\n</tr>\n<tr>\n<td><strong>Dose</strong></td>\n<td>7000-8000 cGy</td>\n<td>6000 cGy</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e3ce586ef69f426cac36b26d45f3259ex1280x1211.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1031",
      "difficulty": "medium"
    },
    {
      "text": "A 12 year old girl presents to the emergency department after sustaining electrical burn injuries of 10% total body surface area. Her bodyweight is 40 kg. What is the amount of fluid that must be administered within the first 8 hours after burn injury?",
      "choices": [
        {
          "id": 1,
          "text": "1,600 mL"
        },
        {
          "id": 2,
          "text": "800 mL"
        },
        {
          "id": 3,
          "text": "600 mL"
        },
        {
          "id": 4,
          "text": "400 mL"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In <strong>electrical injuries,&nbsp;</strong>adjusted fluid rates are given at a rate of<strong>&nbsp;4ml LR x kg x %TBSA </strong>until urine clears.</p>\n<p>The calculated fluid volume is initiated in the following manner: (a 40-kg girl with 10% TBSA burns requires 4 &times; 40 &times; 10 = <strong>1,600 mL in 24 hours</strong>).</p>\n<p>One-half of that volume <strong>(800 mL)</strong> should be provided in the <strong>first 8 hours</strong>.</p>\n<p>The remaining one-half of the total fluid is administered during the subsequent 16 hours.</p><p><strong>In electric injury,&nbsp;</strong>the current enters at one point and then leaves the body at an exit point, usually to the earth or the neutral conductor of the electricity supply.&nbsp;It tends to take the&nbsp;<strong>shortest route&nbsp;</strong>between&nbsp;<strong>entry and best exit</strong>, irrespective of the varying conductivity of different internal tissues.</p>\n<p>When a hand is brought into contact with a live conductor, and the body is earthed either through the feet or the opposite hand, the&nbsp;<strong>most common&nbsp;</strong>passage of current is<strong>&nbsp;across the heart.</strong></p>\n<p>It has been claimed that<strong>&nbsp;the most dangerous current path&nbsp;</strong>is contacted&nbsp;<strong>with the right hand&nbsp;</strong>and&nbsp;<strong>exit through the left foot</strong>, as this causes the maximum&nbsp;<strong>(up to 8.5 percent)&nbsp;</strong>of the total body current to flow<strong>&nbsp;through the heart</strong>&nbsp;when compared with head to feet (up to 5.9 percent), left hand to feet (up to 5.1 percent), hand to hand (up to 4.4 percent) or foot to foot (up to 0.4 percent)</p>\n<p>Direct current<strong>&nbsp;(d.c.)</strong>&nbsp;<strong>is less dangerous</strong>&nbsp;than alternating current (a.c.).&nbsp;<strong>Most deaths&nbsp;</strong>from electricity are<strong>&nbsp;from cardiac arrhythmias</strong>, usually, ventricular fibrillation ending in cardiac arrest.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8b7108ea737840f6b70f54d74c5c5d1ax1280x1780.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Burns – Formulae for Fluid Calculation(Updated according to ATLS 10th edition 2018 guidelines)</h3><p><strong>Parkland’s formula</strong> gives the total fluid requirement for 24hours. <strong>Half</strong> of this volume is infused in the <strong>first 8 hours</strong>, and the <strong>remaining half</strong> is infused in the <strong>next 16 hours</strong>.</p>\n<p>This formula is recommended for those who have sustained large <strong>deep partial-thickness or full-thickness burns</strong> that cover more than 20% of the TBSA in adults and more than 10% in children. </p>\n<p>Formulas provide a <strong>starting target rate</strong>; Subsequently, the amount of fluid provided should be adjusted based on <strong>urine output</strong>.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Category of burn</strong></td>\n<td><strong>Age</strong></td>\n<td><strong>Amount of Ringer’s Lactate given for 24 hours (ml)</strong></td>\n<td><strong>Target urine output (ml/kg/hour)</strong></td>\n</tr>\n<tr>\n<td rowspan=\"3\"><strong>2nd/3rd-degree burns</strong></td>\n<td>Adults </td>\n<td>2 x weight in kgs x % TBSA</td>\n<td>0.5</td>\n</tr>\n<tr>\n<td>&lt;14 years</td>\n<td>3 x weight in kgs x % TBSA</td>\n<td>1</td>\n</tr>\n<tr>\n<td>&lt; 1 year or &lt;30kgs</td>\n<td>3 x weight in kgs x % TBSA + 5% dextrose on a maintenance rate</td>\n<td>1</td>\n</tr>\n<tr>\n<td><strong>4th-degree burns / Electrical burns</strong></td>\n<td>All ages</td>\n<td>4 x weight in kgs x % TBSA</td>\n<td>1-1.5 (until urine clears)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Dextrose maintenance:</strong></p>\n<ul>\n<li aria-level=\"1\">100 ml/ kg in 24 hours for 10 kg</li>\n<li aria-level=\"1\">50 ml/kg for next 10 kg</li>\n<li aria-level=\"1\">20 ml/kg for every kg after 20 kg</li>\n</ul>\n<p><strong>Evan’s formula</strong> is used for <strong>normal saline</strong>.</p>\n<p>For the first 24 hours:</p>\n<ul>\n<li aria-level=\"1\">Amount of NS administered = weight in kgs x % TBSA</li>\n<li aria-level=\"1\">Amount of colloid administered = weight in kgs x % TBSA</li>\n<li aria-level=\"1\">5% Dextrose administered= 2000 ml</li>\n</ul>\n<p>After 24 hours, the amount of NS and colloid administered is half. 2000 ml of dextrose is maintained.</p>\n<p><strong>Muir and Barclay’s formula</strong> for colloids:</p>\n<ul>\n<li>1 portion of colloid = (weight in kgs x % TBSA)/2</li>\n<li>6 portions of colloid are administered over 36 hours</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6311",
      "difficulty": "medium"
    },
    {
      "text": "Maximum incidence of Ewing’s sarcoma is seen in ___________.",
      "choices": [
        {
          "id": 1,
          "text": "1st decade"
        },
        {
          "id": 2,
          "text": "2nd decade"
        },
        {
          "id": 3,
          "text": "3rd decade"
        },
        {
          "id": 4,
          "text": "4th decade"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Ewing&rsquo;s sarcoma is the most common malignancy of first decade but its incidence is maximum in second decade.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1214",
      "difficulty": "medium"
    },
    {
      "text": "A 30-year-old man is brought to the ER with complaints of excessive vomiting following alcohol ingestion. On examination, you notice slurred speech and horizontal gaze nystagmus. What will be the likely alcohol content in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Around 30 mg%"
        },
        {
          "id": 2,
          "text": "Around 40 mg%"
        },
        {
          "id": 3,
          "text": "Around 60 mg%"
        },
        {
          "id": 4,
          "text": "Around 80 mg%"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>In isolated ethanol intoxication, the occurrence of <strong>horizontal gaze nystagmus</strong> indicates a <strong>BAC level</strong> of around <strong>80 mg/dl</strong>. It has a 70-80% sensitivity.</p>\n<p>Horizontal gaze nystagmus has been shown to correlate highly with both BAC and cognitive impairment.&nbsp;</p>\n<p>The HGN test assesses lack of smooth pursuit, sustained endpoint nystagmus, and induced nystagmus prior to a lateral gaze angle of 45 degrees.</p>\n<p>BAC levels corresponding to the clinical features are:</p>\n<table>\n<tbody>\n<tr>\n<td><span><strong>Blood alcohol concentration</strong></span></td>\n<td><span><strong>Effects</strong></span></td>\n</tr>\n<tr>\n<td>0 to 50mg%</td>\n<td>No significant or mild euphoria</td>\n</tr>\n<tr>\n<td>50 to 100mg%</td>\n<td>Decreased inhibition, increased self-confidence, decreased attention span, slurring of speech, alteration of judgment, nystagmus</td>\n</tr>\n<tr>\n<td>100 to 150mg%</td>\n<td>Mental confusion, emotional instability, loss of critical judgment, ataxia, impaired memory, sleepiness</td>\n</tr>\n<tr>\n<td>150 to 300mg%</td>\n<td>Loss of muscular coordination, staggering gait, drowsiness, exaggeration of emotions, dizziness, disorientation, decreased pain response</td>\n</tr>\n<tr>\n<td>300 to 400mg%</td>\n<td>Stupor, marked incoordination, possibly coma</td>\n</tr>\n<tr>\n<td>400mg% and above</td>\n<td>Anesthesia, depression of response, respiratory failure, deep coma, death</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3812",
      "difficulty": "medium"
    },
    {
      "text": "Following normal vaginal delivery, a patient developed PPH and lost about 700mL of blood. Her PR was 100 bpm and her BP was 100/60mmHg. What is the value and corresponding interpretation of her shock index?",
      "choices": [
        {
          "id": 1,
          "text": "0.7 - normal"
        },
        {
          "id": 2,
          "text": "0.7 - significant"
        },
        {
          "id": 3,
          "text": "1 - significant"
        },
        {
          "id": 4,
          "text": "1 - normal"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Shock index = <strong>1</strong> and it indicates <strong>significant</strong> blood loss.</p>\n<p>The shock index is calculated as <strong>HR/systolic BP.</strong></p>\n<p>Here, PR=100 and systolic BP=100.</p>\n<p>Shock Index = 100/100 = 1</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Description</strong></td>\n<td><strong>Range of shock index</strong></td>\n</tr>\n<tr>\n<td>Normal value of shock index (non-pregnant)</td>\n<td>0.5 - 0.7</td>\n</tr>\n<tr>\n<td>Normal value of shock index in pregnant (i.e) Obstetrical shock index</td>\n<td>0.7 - 0.8</td>\n</tr>\n<tr>\n<td>Significant or massive blood loss</td>\n<td>0.9 - 1.1</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>If the shock index is 0.9 &ndash; 1.1, it indicates massive blood loss and the need for intensive <strong>resuscitation</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9721",
      "difficulty": "medium"
    },
    {
      "text": "What are the net number of ATP’s generated in rapaport leubering cycle ?",
      "choices": [
        {
          "id": 1,
          "text": "4"
        },
        {
          "id": 2,
          "text": "2"
        },
        {
          "id": 3,
          "text": "0"
        },
        {
          "id": 4,
          "text": "1"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The net number of ATPs generated in the <strong>Rapaport Luebering cycle(2,3 BPG shunt pathway)</strong> is <strong>zero</strong>. 2 ATPs are generated at the pyruvate kinase step, but that is used up by hexokinase and fructokinase.</p>\n<p><strong>Rapaport luebering cycle:</strong></p>\n<div class=\"page\" title=\"Page 132\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>In the erythrocytes. Bisphosphoglycerate mutase converts 1,3-bisphosphoglycerate (BPG) to 2,3-BPG. Then BPG-phosphatase removes the phosphate group to form 3-phosphoglycerate</p>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/83493a6d45f343ac9ae491f9f389b407x1280x461.JPEG\" alt=\"Explanation Image\"><div class=\"page\" title=\"Page 132\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Significance of BPG</p>\n<ul>\n<li>2,3-BPG binds to hemoglobin and reduces the affinity towards oxygen. So, in the presence of 2,3- BPG, oxyhemoglobin will unload oxygen more easily in tissues.</li>\n<li>Under hypoxic conditions the 2,3-BPG concentration in the RBC increases, thus favoring the release of oxygen to the tissues even when pO2 is low.</li>\n<li>The compensatory increase in 2,3-BPG in high altitudes favors oxygen dissociation. BPG affinity is decreased in fetal circulation.</li>\n</ul>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5768",
      "difficulty": "medium"
    },
    {
      "text": "What is the dose of ulipristal for emergency contraception?",
      "choices": [
        {
          "id": 1,
          "text": "60 µg"
        },
        {
          "id": 2,
          "text": "3 mg"
        },
        {
          "id": 3,
          "text": "30 mg"
        },
        {
          "id": 4,
          "text": "30 µg"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The dose of <strong>ulipristal</strong> is <strong>30 mg</strong> tablet and it should be taken <strong>within 5 days&nbsp;</strong>of intercourse.</p>\n<p>Ulipristal is a synthetic progesterone receptor modulator. It attaches to the progesterone receptor and acts by:</p>\n<ul>\n<li>Preventing/delaying ovulation</li>\n<li>Suppressing endometrial and follicular growth</li>\n<li>Inhibiting implantation</li>\n</ul>\n<p><strong>Side effects</strong> are <strong>headaches</strong> and <strong>mood changes</strong>. It is <strong>contraindicated</strong> in women with severe <strong>hepatic dysfunction</strong> and severe <strong>asthma</strong>.</p>\n<p>Note: The use of ulipristal for the treatment of fibroids has been discontinued due to the increased incidence of severe liver injury.</p><hr><h3>Related Pearl: Hormonal contraceptives</h3><div dir=\"ltr\">\n<p><strong>Oral pills:</strong></p>\n<ul>\n<li>Combined oral contraceptive pills (COC)\n<ul>\n<li>Mala D -&nbsp;Levonorgestrel 0.15 mg + Ethinyl estradiol &nbsp;0.03 mg + Ferrous fumarate</li>\n<li>Mala N -&nbsp;Levonorgestrel 0.15 mg +&nbsp;Ethinyl estradiol &nbsp;0.03 mg + Ferrous fumarate&nbsp;(Govt. supply, free of cost)</li>\n</ul>\n</li>\n<li>Progesterone only pills (POP) - suitable for lactating women\n<ul>\n<li>Norethisterone 350 &mu;g</li>\n<li>Norgestrel 75 &mu;g</li>\n<li>Levonorgestrel (LNG) 30 &mu;g</li>\n</ul>\n</li>\n<li>Once a month or long-acting pills - highly disappointing results\n<ul>\n<li>Quinestrol (long-acting estrogen) + short-acting progesterone</li>\n</ul>\n</li>\n<li>Gossypol - male pill : Cottonseed derivative and causes azoospermia and severe oligospermia</li>\n<li>Post-coital pills or interceptive\n<ul>\n<li>Levonorgestrel 0.75 mg, 2 doses, 12 hours apart</li>\n<li>Mifepristone 10-600 mg</li>\n<li>Ulipristal 30 mg, within 5 days of intercourse</li>\n<li>Centchroman 60 mg, 2 tablets, within 24 hrs of intercourse</li>\n<li>GnRH agonists &nbsp;</li>\n<li>CuT IUCD, inserted within 5 days</li>\n</ul>\n</li>\n</ul>\n<p><strong> Injectable contraceptives</strong></p>\n<ul>\n<li>Progesterone only injectables\n<ul>\n<li>DMPA&nbsp;150 mg IM every 3 months</li>\n<li>NET-EN&nbsp;200 mg IM every 2 months</li>\n</ul>\n</li>\n<li>Combined injectables\n<ul>\n<li>Cyclofem - DMPA 25 mg + Estradiol cypionate 5 mg</li>\n<li>Mesigyna - NET-EN 50 mg &nbsp;+ Estradiol valerate 5 mg</li>\n</ul>\n</li>\n</ul>\n<p><strong> Subdermal implants</strong></p>\n<ul>\n<li>Norplant I -&nbsp;Levonorgestrel 35 mg</li>\n<li>Norplant II or Jadelle -&nbsp;2 rods with levonorgestrel 70 mg in each and released at a rate of 50 &mu;g/day &nbsp;</li>\n</ul>\n<p><strong>Others</strong></p>\n<ul>\n<li>Hormonal IUCD -&nbsp;Mirena which contains LNG 52 mg with release rate of&nbsp;20 &mu;g/day</li>\n<li>Orthoevra patch -&nbsp;Norelgestomin + Ethinyl estradiol weekly for 3 weeks, then patch free for 1 week</li>\n<li>Vaginal ring or Nuvaring - Etonogestrel + ethinyl estradiol daily release, use for 3 weeks with withdrawal for 1 week</li>\n</ul>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6953",
      "difficulty": "medium"
    },
    {
      "text": "Concentration of Bupivacaine used for “mobile” epidural is ___________.",
      "choices": [
        {
          "id": 1,
          "text": "0.0625%"
        },
        {
          "id": 2,
          "text": "0.125%"
        },
        {
          "id": 3,
          "text": "0.25%"
        },
        {
          "id": 4,
          "text": "0.5%"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>0.0625% Bupivacaine is used for mobile epidural.</p>\n<p>Very dilute local anesthetic mixtures (0.0625%) generally do not produce motor blockade and allow patients to ambulate (&ldquo;walking&rdquo; or &ldquo;mobile&rdquo; epidural).</p>\n<p>Concentrations of local anesthetics used for epidural analgesia:</p>\n<ul>\n<li>Without opioid\n<ul>\n<li>Bupivacaine: 0.25%</li>\n<li>Ropivacaine: 0.2%</li>\n</ul>\n</li>\n<li>With opioid:\n<ul>\n<li>Bupivacaine 0.0625% to 0.125%</li>\n<li>Ropivacaine 0.0625% to 0.2%</li>\n</ul>\n</li>\n</ul>\n<p>Note:</p>\n<ul>\n<li>Bupivacaine and Ropivacaine are preferred over lidocaine and chloroprocaine for labor analgesia because of their differential blockade.</li>\n<li>They produce less motor blockade as compared to sensory blockade. This preserved motor function enables voluntary bearing down efforts.</li>\n<li>Bupivacaine is preferred because of its long duration of action</li>\n<li>Ropivacaine has lower cardiac toxicity</li>\n<li>Lower the concentration of the local anesthetic the greater the concentration of opioid that is required</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3919",
      "difficulty": "hard"
    },
    {
      "text": "The dose of iodine for lactating women in India according to the recommended dietary allowance is:",
      "choices": [
        {
          "id": 1,
          "text": "200 μg/day"
        },
        {
          "id": 2,
          "text": "220 μg/day"
        },
        {
          "id": 3,
          "text": "250 μg/day"
        },
        {
          "id": 4,
          "text": "280 μg/day"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>According to the National Institute of Nutrition (NIN) 2020 guidelines, the recommended dietary allowance (<strong>RDA</strong>) for dietary iodine in <strong>lactating women</strong> in India is <strong>280 μg/day.</strong></p>\n<p>NIN guidelines on recommended dietary allowance for iodine per day:</p>\n<table>\n<tbody>\n<tr>\n<th scope=\"col\">Age</th>\n<th scope=\"col\">Male</th>\n<th scope=\"col\">Female</th>\n</tr>\n<tr>\n<td scope=\"row\">Birth to 6 months</td>\n<td align=\"right\">100 mcg</td>\n<td align=\"right\">100 mcg</td>\n</tr>\n<tr>\n<td scope=\"row\">7–12 months</td>\n<td align=\"right\">130 mcg</td>\n<td align=\"right\">130 mcg</td>\n</tr>\n<tr>\n<td scope=\"row\">1–9 years</td>\n<td align=\"right\">90-120 mcg</td>\n<td align=\"right\">90-120 mcg</td>\n</tr>\n<tr>\n<td scope=\"row\">10–12 years</td>\n<td align=\"right\">150 mcg</td>\n<td align=\"right\">150 mcg</td>\n</tr>\n<tr>\n<td scope=\"row\">14–18 years</td>\n<td align=\"right\">150 mcg</td>\n<td align=\"right\">150 mcg</td>\n</tr>\n<tr>\n<td scope=\"row\">&gt; 19 years</td>\n<td align=\"right\">150 mcg</td>\n<td align=\"right\">150 mcg</td>\n</tr>\n<tr>\n<td scope=\"row\">Pregnancy</td>\n<td align=\"right\"> —</td>\n<td align=\"right\">250 mcg</td>\n</tr>\n<tr>\n<td scope=\"row\">Lactation</td>\n<td align=\"right\"> —</td>\n<td align=\"right\">280 mcg</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Note: According to the <strong>WHO</strong> guidelines, the RDA during both pregnancy and lactation is <strong>250</strong> <strong>mcg</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4406",
      "difficulty": "hard"
    },
    {
      "text": "The number of ASHA visits after home delivery is ______",
      "choices": [
        {
          "id": 1,
          "text": "4"
        },
        {
          "id": 2,
          "text": "5"
        },
        {
          "id": 3,
          "text": "6"
        },
        {
          "id": 4,
          "text": "7"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>ASHA home visits:</p>\n<ul>\n<li>7 visits after home delivery (on days 1, 3, 7, 14, 21, 28 and 42)</li>\n<li>6 visits after institutional delivery (no visit on day 1)</li>\n<li>5 visits to those born in a facility through LSCS (no visits on day 1 and day 3)</li>\n</ul>\n<p>The total incentive received by ASHA for HBNC (Home-based newborn care) is Rs.250.</p><hr><h3>Related Pearl: ASHA</h3><p>ASHA stands for&nbsp;<strong>Accredited Social Health Activist.</strong></p>\n<p>General norms with respect to ASHA workers:</p>\n<ul>\n<li>Must be a <strong>woman</strong>&nbsp;in the age group of 25-45 years -&nbsp;married/divorced/widow</li>\n<li>Must be a <strong>resident</strong> of that village</li>\n<li>Formal education of up to <strong>10<sup>th</sup> standard&nbsp;</strong>\n<ul>\n<li>If no candidates are available, the requirement can be relaxed to the 8<sup>th</sup> standard</li>\n</ul>\n</li>\n<li>At least <strong>1 ASHA</strong> for a <strong>population of 1000&nbsp;</strong>\n<ul>\n<li>In tribal, hilly, and desert areas, the norm can be relaxed to 1 ASHA per habitation</li>\n</ul>\n</li>\n</ul>\n<p>States can relax the norms on population and educational qualifications on a case-to-case basis, depending on the local conditions. However, these are exceptions and not the general norm.</p>\n<p><strong>Responsibilities </strong>of ASHA:</p>\n<ul>\n<ul>\n<li>Health <strong>education</strong> and awareness</li>\n<li><strong>Reproductive and child health</strong> and family planning</li>\n<li>Facilitate the access to health services</li>\n<li>Promotion of <strong>sanitation</strong> and household toilet construction</li>\n<li>Provision of primary medical care for <strong>minor ailments</strong></li>\n<li>Provider of <strong>DOTS</strong></li>\n<li><strong>Depot holder</strong> of essentials like ORS, iron and folic acid tablets, condoms, disposable delivery kits, etc.</li>\n<li>Dispersal of <strong>health information</strong> on her community to higher centres</li>\n<li>Some responsibilities are integrated with Anganwadi workers and Auxiliary Nurse Midwife</li>\n</ul>\n</ul>\n<p>Home visits by ASHA under Home-based Newborn care (HBNC)&nbsp;</p>\n<ul class=\"p-rich_text_list p-rich_text_list__bullet\" data-stringify-type=\"unordered-list\" data-indent=\"0\" data-border=\"0\">\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\"><strong>7 visits</strong> after <strong>home delivery</strong> (on days 1, 3, 7, 14, 21, 28 and 42)</li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\"><strong>6 visits</strong> after <strong>institutional delivery</strong> (on days 3, 7, 14, 21, 28 and 42) in case of a <strong>vaginal delivery</strong>; and <strong>5 visits</strong> in cases of <strong>Caesarean section</strong> delivery, where the mother returns home after 5-6 days, i.e, on days - 7, 14, 21, 28 and 42.</li>\n</ul>\n<p>Home visits by ASHA under Home-based care of young child (HBYC)</p>\n<ul>\n<li>A total of&nbsp;<strong>5 visits</strong>&nbsp;are scheduled&nbsp;<strong>after 42 days</strong>&nbsp;under the&nbsp;<strong>Home-Based Care of the Young Child(HBYC).</strong></li>\n<li>ASHA will provide <strong>quarterly home visits</strong> on the 3rd, 6th, 9th, 12th and 15th months</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6576",
      "difficulty": "medium"
    },
    {
      "text": "In painful arc sign, the pain during abduction of shoulder occurs within _______",
      "choices": [
        {
          "id": 1,
          "text": "0-60°"
        },
        {
          "id": 2,
          "text": "60°-120°"
        },
        {
          "id": 3,
          "text": "More than 120°"
        },
        {
          "id": 4,
          "text": "None of the above"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Painful arc sign is seen in <strong>impingement syndrome</strong> which is due to repeated rubbing of the tendon (mainly <strong>supraspinatus</strong>) under coraco acromial arc.</p>\n<p>Patient complaints of increased pain when the arm traverses an arc between <strong>60 and 120 degrees </strong>when greater tuberosity negotiates the subacromial space.</p>\n<p><strong>Other tests include Neers impingement sign and Hawkins-Kennedy test.</strong></p><img src=\"https://cdn1.dailyrounds.org/uploads/af011b05c444495e97e0173aab55ee3dx366x427.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6577",
      "difficulty": "easy"
    },
    {
      "text": "A 20 year old boy was brought to casualty with a history of RTA and head trauma. His eye opens to verbal command, he responds with inappropriate words and right hand flexes to painful stimuli and localizes pain on the left hand and both legs in extended posture. Calculate his Glasgow Coma Score (GCS).",
      "choices": [
        {
          "id": 1,
          "text": "13"
        },
        {
          "id": 2,
          "text": "11"
        },
        {
          "id": 3,
          "text": "9"
        },
        {
          "id": 4,
          "text": "10"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The GCS scale of this patient is E3 V3 M5, which comes to a total score of 11.</p>\n<ul>\n<li>E3 - Eye opens to loud voice</li>\n<li>M5 - Localize to pain(the score represents the best performance elicited, so a patient flexing in response to a painful stimulus on the right and localising pain on the left scores ‘M5’.)</li>\n<li>V3 - Inappropraiate words.</li>\n</ul><hr><h3>Related Pearl: Glasgow Coma Scale (GCS)</h3><div class=\"ng-scope\">\n<p><strong>GCS Score</strong></p>\n<ul>\n<li class=\"ng-binding ng-scope\">13-15 represent mild injury</li>\n<li>9-12 represent moderate injury</li>\n<li>Scores ≤8 represent severe injury </li>\n</ul>\n</div>\n<div class=\"ng-scope\">\n<p><strong>Head Injury Severity: Clinical classification</strong> </p>\n</div>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Eyes Opening</strong></p>\n</td>\n<td><strong>Score</strong></td>\n</tr>\n<tr>\n<td>Spontaneously</td>\n<td>4</td>\n</tr>\n<tr>\n<td>To verbal command</td>\n<td>3</td>\n</tr>\n<tr>\n<td>To painful stimulus</td>\n<td>2</td>\n</tr>\n<tr>\n<td>Do not open</td>\n<td>1</td>\n</tr>\n<tr>\n<td>\n<div class=\"page\" title=\"Page 163\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Non-testable</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>NT</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>\n<table>\n<tbody>\n<tr>\n<td><strong>Verbal response</strong></td>\n<td><strong>Score</strong></td>\n</tr>\n<tr>\n<td>Normal-oriented conversation</td>\n<td>5</td>\n</tr>\n<tr>\n<td>Confused</td>\n<td>4</td>\n</tr>\n<tr>\n<td>Inappropriate words only</td>\n<td>3</td>\n</tr>\n<tr>\n<td>Sounds only</td>\n<td>2</td>\n</tr>\n<tr>\n<td>No sounds</td>\n<td>1</td>\n</tr>\n<tr>\n<td>\n<div class=\"page\" title=\"Page 163\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Non-testable</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>NT</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>\n<table>\n<tbody>\n<tr>\n<td><strong>Motor Response</strong></td>\n<td><strong>Score</strong></td>\n</tr>\n<tr>\n<td>Obeys commands</td>\n<td>6</td>\n</tr>\n<tr>\n<td>Localizes to pain</td>\n<td>5</td>\n</tr>\n<tr>\n<td>Withdrawal response to pain</td>\n<td>4</td>\n</tr>\n<tr>\n<td>Abnormal flexion/ Decorticate posturing </td>\n<td>3</td>\n</tr>\n<tr>\n<td>Abnormal extension/ Decerebrate posturing </td>\n<td>2</td>\n</tr>\n<tr>\n<td>No motor response</td>\n<td>1</td>\n</tr>\n<tr>\n<td>\n<div class=\"page\" title=\"Page 163\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Non-testable</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>NT</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Minimum value: </strong>3</p>\n<p><strong>Maximum value:</strong> 15</p>\n<ul>\n<li>GCS, in particular, the <strong>motor score</strong>, is the <strong>best predictor of neurological outcome.</strong></li>\n<li>If an area cannot be assessed, no numerical score is given for that region, and it is considered “non-testable.\" (NT)</li>\n<li>In case of <strong>endotracheal intubation or tracheostomy</strong>, the verbal component of the score is <strong>denoted as NT</strong>.</li>\n<li>A score of  ‘1’ is not recorded in missing components, instead, NT is used</li>\n<li>when a component is Not Testable, a total score is not recorded because the score will be low and this could be confusing to medical colleagues. This may also imply that the patient is more unwell than they actually are.</li>\n</ul>\n<p> </p>\n<div class=\"page\" title=\"Page 163\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>NOTE: </strong></p>\n<p>A new parameter, \"pupil reactivity score\" has been added to GCS, and now, it is referred to as GCS-P.</p>\n</div>\n</div>\n</div>\n<p>P stands for \"Pupils unreactive to light\"</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Pupils unreactive to light</strong></td>\n<td><strong>Score</strong></td>\n</tr>\n<tr>\n<td>Both pupils</td>\n<td>2</td>\n</tr>\n<tr>\n<td>One pupil</td>\n<td>1 </td>\n</tr>\n<tr>\n<td>Neither</td>\n<td> 0</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>The pupillary score is subtracted</strong> from the GCS score to give the final value. Therefore, the range of GCS-P is 1–15.</p>\n<p><strong>Note:</strong> The minimum frequency of observations for patients with GCS equal to 15 should be as follows, starting after the initial assessment in the emergency department:</p>\n<ul>\n<li class=\"p-rich_text_section\">Half-hourly for 2 hours,</li>\n<li class=\"p-rich_text_section\">Then 1-hourly for 4 hours,</li>\n<li class=\"p-rich_text_section\">2-hourly thereafter.</li>\n</ul>\n<p>Should the patient with GCS equal to 15 deteriorate at any time after the initial 2-hour period, observations should revert to half-hourly and follow the original frequency schedule.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6533",
      "difficulty": "medium"
    },
    {
      "text": "McNaughten's rule falls under which Section?<div class='question-desc-html'><p>BNS- Bharatiya Nyaya Sanhita<br />BNSS- Bharatiya Nagarik Suraksha Sanhita</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "BNSS Section 85 (CrPC 83)"
        },
        {
          "id": 2,
          "text": "BNS Section 22  (IPC 84)"
        },
        {
          "id": 3,
          "text": "BNS Section 219  (IPC 184)"
        },
        {
          "id": 4,
          "text": "BNSS Section 204  (CrPC 184)"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p class=\"p1\">McNaughten's rule falls under <strong>Section 22</strong> of the <strong>Bharatiya Nyaya Sanhita (IPC 84). </strong></p>\n<p class=\"p1\">It states, \"A person of unsound mind is <strong>not liable</strong> for an act.\"</p>\n<p class=\"p1\">Defect: In Mc Naughthen’s rule, only intellectual factors are considered but emotions, delusion, and control of impulses are ignored.</p><hr><h3>Related Pearl: BNS section 22, M'Naghten's rule</h3><p><strong>M'Naghten's rule, BNS 22 (Previously - Section 84 IPC): </strong> Criminal responsibility of the insane.</p>\n<p>Nothing is an offence which is done by a person who, at the time of doing it, by reason of unsoundness of mind, is incapable of knowing the nature of the act, or that he is doing what is either wrong or contrary to law.</p><hr><h3>Related Pearl: Criminal Responsibilities</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>BNS section</strong></p>\n</td>\n<td>\n<p><strong>Previous IPC Section</strong></p>\n</td>\n<td>\n<p><strong>Deals with</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p> 18</p>\n</td>\n<td>\n<p>-</p>\n</td>\n<td>\n<p>Not liable</p>\n<p>If done by accident or misfortune and without any criminal intention or knowledge in the doing of a lawful act in a lawful manner by lawful means and with proper care and caution.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p> 20</p>\n</td>\n<td>\n<p>82</p>\n</td>\n<td>\n<p>A child under 7 years is not liable for the act.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>21</p>\n</td>\n<td>\n<p>83</p>\n</td>\n<td>\n<p>Child of 7–12 years if not attained proper mental maturity is not liable for the act.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>22</p>\n</td>\n<td>\n<p>84  </p>\n</td>\n<td>\n<p><strong>McNaughten's rule: </strong>A person of unsound mind is not liable for the act.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>23</p>\n</td>\n<td>\n<p>85</p>\n</td>\n<td>\n<p>A person who under involuntary intoxication has commited an act is not liable for the act.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>24</p>\n</td>\n<td>\n<p>86</p>\n</td>\n<td>\n<p>A person who under voluntary intoxication commits an act is liable for the act.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2291",
      "difficulty": "easy"
    },
    {
      "text": "Under the Mid-Day Meal (MDM) scheme, supplementary nutrition provided should cover at least _______",
      "choices": [
        {
          "id": 1,
          "text": "1/3 of the total protein requirement + ½ of total energy requirement"
        },
        {
          "id": 2,
          "text": "2/3 of the total protein requirement + ½ of total energy requirement"
        },
        {
          "id": 3,
          "text": "½ of the total protein requirement + 1/3 of total energy requirement"
        },
        {
          "id": 4,
          "text": "½ of the total protein requirement + 2/3 of total energy requirement"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Under the<strong> Mid-Day Meal</strong> (MDM) <strong>scheme</strong>, supplementary nutrition provided must cover at least <strong>&frac12; of the total protein requirement and 1/3 of total energy requirement</strong> to children in schools.</p>\n<p>The MDM scheme is also called <strong>School Lunch Programme</strong> and has been operational since 1961 in India. Currently, it functions under the broad coverage of the<strong> Minimum Needs Programme</strong>.</p>\n<p>Some other principles of the MDM are:</p>\n<ul>\n<li>The meal provided under the MDM should only be a <strong>supplement</strong> and not a substitute to home diets.</li>\n<li>The<strong> cost of the meals should be reasonably low.</strong></li>\n<li>The meal should be <strong>easy to cook</strong> in schools.</li>\n<li><strong>Locally available foods</strong> must be used, for as far as possible.</li>\n<li>The menu should be <strong>regularly changed</strong> to avoid monotony.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9178",
      "difficulty": "medium"
    },
    {
      "text": "A 47-year-old phlebotomist suffered a needle-stick injury while drawing blood from a patient with HIV. Which of the following mutations in him can cause a resistance to acquiring HIV infection?",
      "choices": [
        {
          "id": 1,
          "text": "CXCR4 2q21 mutation"
        },
        {
          "id": 2,
          "text": "HLA B*35"
        },
        {
          "id": 3,
          "text": "CCR5 delta 32 mutation"
        },
        {
          "id": 4,
          "text": "DC-SIGN"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>CCR 5 delta 32 mutation</strong> causes <strong>resistance</strong> <strong>to HIV infection</strong>. It&nbsp;is a mutated allele that causes a <strong>lack</strong> of surface expression of the <strong>CCR5</strong> co-receptor resulting in blockade of HIV entry and resistance to HIV infection.</p>\n<p>Homozygous alleles cause complete resistance to HIV infection &amp; heterozygous alleles cause partial resistance.</p>\n<p><strong>CXCR4 </strong>and<strong> CCR5</strong> are <strong>chemokine receptors</strong> (co-receptors) present on the surface of CD4+ T-helper&nbsp;cells &amp; macrophages that aid in the <strong>fusion and entry</strong> of the HIV virus.&nbsp;</p>\n<p><strong>DC-SIGN</strong> is a type of cell surface lectin receptor to which the HIV virus has the affinity to bind. The expression of this type of receptor on dendritic cells (antigen-presenting cells)<strong> enhances the infectivity</strong> of HIV.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1607",
      "difficulty": "medium"
    },
    {
      "text": "Population growth is said to be explosive , if annual growth rate  exceeds",
      "choices": [
        {
          "id": 1,
          "text": "1"
        },
        {
          "id": 2,
          "text": "2"
        },
        {
          "id": 3,
          "text": "0.5"
        },
        {
          "id": 4,
          "text": "1.5"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><span><strong>Relation between growth rate and population</strong></span></p>\n<table>\n<tbody>\n<tr>\n<td><strong>RATING</strong></td>\n<td><strong>ANNUAL GROWTH RATE IN %</strong></td>\n</tr>\n<tr>\n<td>Stationery</td>\n<td>\n<p>no growth&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>slow growth&nbsp;</p>\n</td>\n<td>less than 0.5&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>moderate growth&nbsp;</p>\n</td>\n<td>0.5 to 1</td>\n</tr>\n<tr>\n<td>\n<p>rapid growth</p>\n</td>\n<td>1 to 1.5&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>very rapid growth</p>\n</td>\n<td>1.5 to 2</td>\n</tr>\n<tr>\n<td><strong>explosive growth</strong></td>\n<td><strong>&nbsp;more than 2</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3602",
      "difficulty": "medium"
    },
    {
      "text": "Nonavalent HPV vaccine works against which of the following strains of the virus?",
      "choices": [
        {
          "id": 1,
          "text": "1, 6, 11, 16, 18, 31, 45, 52, 58"
        },
        {
          "id": 2,
          "text": "6, 11, 16, 18, 31, 33, 45, 52, 58"
        },
        {
          "id": 3,
          "text": "1, 16, 18, 21, 33, 45, 48, 52, 58"
        },
        {
          "id": 4,
          "text": "6, 11, 16, 18, 33, 45, 48, 52, 58"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p>The <strong>nonavalent HPV vaccine</strong> works against strains <strong>6, 11, 16, 18, 31, 33, 45, 52 </strong>and <strong>58</strong>.</p>\n<p>There are three primary HPV vaccines - bivalent, quadrivalent and nonavalent - depending on the HPV types they confer immunity against.</p>\n<ul>\n<li><strong>Bivalent</strong> vaccine (<strong>Cervarix</strong>) works against HPV types 16 and 18.</li>\n<li><strong>Quadrivalent</strong> vaccine (<strong>Gardasil</strong>) works against HPV types 6, 11, 16 and 18.</li>\n<li><strong>Nonavalent</strong> vaccine (<strong>Gardasil-9</strong>) works against types 6, 11, 16, 18, 31, 33, 45, 52 and 58. It is also used for the prevention of oropharyngeal and other head and neck cancers. </li>\n</ul>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3578",
      "difficulty": "easy"
    },
    {
      "text": "What is the critical angle of the air-cornea interface?",
      "choices": [
        {
          "id": 1,
          "text": "46 degrees"
        },
        {
          "id": 2,
          "text": "64 degrees"
        },
        {
          "id": 3,
          "text": "24 degrees"
        },
        {
          "id": 4,
          "text": "36 degrees"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The <strong>critical angle</strong> of the air–cornea interface is <strong>46 degrees. </strong><strong>Gonioscopy</strong> is a method of <strong>evaluating</strong> the <strong>anterior chamber (AC) angle.</strong></p>\n<p><strong>Direct goniolenses</strong> include the Koeppe, Medical Workshop, Barkan, and Swan–Jacob. <strong>Indirect goniolenses</strong> include Goldmann, Zeiss, and Posner.</p>\n<p>Structures seen on gonioscopy from anterior to posterior are: </p>\n<ul>\n<li><strong>Schwalbe line:</strong> represents the posterior limit of Descemet's membrane</li>\n<li>Trabecular meshwork</li>\n<li>Scleral spur</li>\n<li>Ciliary body and root of the iris</li>\n</ul>\n<p><strong>Shaffers grading</strong> of angle width:</p>\n<p><strong>Grade</strong> <strong>4</strong> (35–45°) is the <strong>widest angle,</strong> characteristic of <strong>myopia</strong> and <strong>pseudophakia;</strong> the ciliary body can be visualized without tilting the lens.<br /><strong>Grade 3</strong><span> (25–35°) is an open-angle in which the </span><strong>scleral spur</strong><span> is visible.<br /></span><strong>Grade 2</strong><span> (20°) is an angle in which the </span><strong>trabeculum</strong><span> but not the scleral spur can be seen.<br /></span><strong>Grade 1</strong><span> (10°) is a very narrow-angle in which </span><strong>only</strong><span> the </span><strong>Schwalbe line,</strong><span> and perhaps the top of the trabeculum, can be identified.<br /></span><strong>A slit angle</strong><span> is one in which there is no obvious iridocorneal contact but no angle structures can be identified.<br /></span><strong>Grade 0</strong><span> (0°) is</span><strong> closed</strong><span> due to </span><strong>iridocorneal contact.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/07c64a6436474c13b1f821debddbb30fx1280x1300.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1348",
      "difficulty": "medium"
    },
    {
      "text": "An abdominal aortic aneurysm is operated when its size is greater than __________",
      "choices": [
        {
          "id": 1,
          "text": "5 cm"
        },
        {
          "id": 2,
          "text": "6 cm"
        },
        {
          "id": 3,
          "text": "5.5 cm"
        },
        {
          "id": 4,
          "text": "6.5 cm"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>An asymptomatic abdominal aortic aneurysm in an otherwise fit patient should be considered for repair if <strong>&gt;5.5 cm </strong>&nbsp;in diameter (measured by ultrasonography). The annual incidence of rupture rises from <strong>1%</strong> or less in aneurysms that are <strong>&lt;5.5 cm</strong> in diameter to a significant level of nearly <strong>25%</strong>, in those that are <strong>7 cm&nbsp; </strong>in diameter.</p>\n<p>As open elective surgery (transabdominal) carries a 5% mortality rate, the balance is in favor of elective operation once the maximum diameter is &gt;5.5 cm.</p>\n<p><strong>6 monthly follow-up ultrasonographic assessment</strong> is indicated for asymptomatic aneurysms &lt;5.5cm in diameter.</p><hr><h3>Related Pearl: Indications for Operative Repair of Aneurysm</h3><table>\n<tbody>\n<tr>\n<td><strong>Condition</strong></td>\n<td><strong>Criteria for surgical repair</strong></td>\n</tr>\n<tr>\n<td>Symptomatic aneurysm</td>\n<td>&nbsp;Any size</td>\n</tr>\n<tr>\n<td>Ascending thoracic aortic aneurysm - asymptomatic</td>\n<td>&gt;5.5 cm</td>\n</tr>\n<tr>\n<td>Descending thoracic aortic aneurysm -&nbsp;asymptomatic</td>\n<td>&gt;6 cm</td>\n</tr>\n<tr>\n<td>Abdominal aortic aneurysm -&nbsp;asymptomatic</td>\n<td>&gt;5.5 cm</td>\n</tr>\n<tr>\n<td>Popliteal artery aneurysm - asymptomatic</td>\n<td>&gt;2-3 cm</td>\n</tr>\n<tr>\n<td>Ascending thoracic aortic aneurysm in Marfan&rsquo;s syndrome or bicuspid aortic valve</td>\n<td>&gt;4-5 cm</td>\n</tr>\n<tr>\n<td>\n<p>Rapidly&nbsp;growing&nbsp;aneurysms&nbsp;</p>\n</td>\n<td>\n<p>&gt;0.5 cm/year for ascending aortic aneurysms</p>\n<p>&gt; 1cm/year for descending aortic aneurysms</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5354",
      "difficulty": "easy"
    },
    {
      "text": "Primary amenorrhoea refers to failure of menstruation beyond the age of _______",
      "choices": [
        {
          "id": 1,
          "text": "12 years"
        },
        {
          "id": 2,
          "text": "14 years"
        },
        {
          "id": 3,
          "text": "15 years"
        },
        {
          "id": 4,
          "text": "18 years"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Primary amenorrhoea</strong> refers to failure if menstruation beyond the age of <strong>15 years</strong> regardless of development of secondary sexual characters.</p>\n<p><strong>Secondary amenorrhoea</strong>&nbsp;absence of menses for more than three months in girls or women who previously had regular menstrual cycles or six months in girls or women who had irregular menses</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5739",
      "difficulty": "medium"
    },
    {
      "text": "According to WHO, the G6PD enzyme activity should be below the following level to be considered as G6PD deficiency and have an increased risk of hemolysis",
      "choices": [
        {
          "id": 1,
          "text": "50"
        },
        {
          "id": 2,
          "text": "60"
        },
        {
          "id": 3,
          "text": "70"
        },
        {
          "id": 4,
          "text": "85"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>G6PD deficeincy is defined as less than 60% of normal enzyme activity by WHO</strong>. Individuals with G6PD deficiency are at an increased risk of hemolysis especially with additional oxidative stress.&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>WHO Class</strong></td>\n<td><strong>Level of deficiency</strong></td>\n<td><strong>Enzyme activity</strong></td>\n<td><strong>Clinical phenotype</strong></td>\n</tr>\n<tr>\n<td><strong>I</strong></td>\n<td>Severe*</td>\n<td>&lt;10%</td>\n<td>Chronic hemolytic anemia</td>\n</tr>\n<tr>\n<td><strong>II</strong></td>\n<td>Severe*</td>\n<td>&lt;10%</td>\n<td>Risk of acute hemolytic anemia; intermittent hemolysis&nbsp;</td>\n</tr>\n<tr>\n<td><strong>III</strong></td>\n<td>Moderate</td>\n<td>10-60%</td>\n<td>Risk of acute hemolytic anemia;&nbsp; hemolysis with stressors&nbsp;&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>* Severe G6PD deficiency can result in either of the two clinical phenotype as described in the table.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4611",
      "difficulty": "medium"
    },
    {
      "text": "A newborn baby at one minute of life has a heart rate 60/min, irregular respiration, with some flexion of limbs. The baby was pale and had a grimace response on passing the nasal catheter. What is the apgar score at one minute?",
      "choices": [
        {
          "id": 1,
          "text": "2"
        },
        {
          "id": 2,
          "text": "3"
        },
        {
          "id": 3,
          "text": "4"
        },
        {
          "id": 4,
          "text": "5"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>This baby has an apgar score of 4.&nbsp;</p>\n<p>Heart rate 60/min- 1</p>\n<p>Irregular respiration- 1</p>\n<p>Some flexion of limbs- 1</p>\n<p>Grimace-1</p>\n<p>The baby was pale-0</p>\n<p class=\"p1\">The Apgar score is a practical method of systematically assessing newborn infants immediately after birth.</p>\n<p class=\"p1\">An infant with a score of 0-3 requires immediate resuscitation.</p><hr><h3>Related Pearl: APGAR score</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b8de3fc0585847cab3e28e1f55d906e2x1279x1330.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5445",
      "difficulty": "medium"
    },
    {
      "text": "You have started a drug Y infusion at a rate of 200 mg/h. Drug Y has Vd of 100 litres and clearance of 100 ml/min. How much will be the drug concentration at steady state ?",
      "choices": [
        {
          "id": 1,
          "text": "50 mg/h"
        },
        {
          "id": 2,
          "text": "25 mg/h"
        },
        {
          "id": 3,
          "text": "36.66 mg/L"
        },
        {
          "id": 4,
          "text": "33.33 mg/L"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Steady state concentration (Css) = Rate of infusion/ clearance </strong></p>\n<ul>\n<li>Rate of infusion = 200 mg/h</li>\n<li>Vd=100L</li>\n<li>Clearance = 100 ml/min = 100 * 60 ml/hr = 6000 ml/hr = 6L/h  (converted to L/h)</li>\n</ul>\n<p>Css = (200 mg/hr) / (6L/hr) = 100/3 = 33.33 mg/L </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4533",
      "difficulty": "medium"
    },
    {
      "text": "Which sensory fibers are least susceptible to hypoxia?",
      "choices": [
        {
          "id": 1,
          "text": "Type I"
        },
        {
          "id": 2,
          "text": "Type II"
        },
        {
          "id": 3,
          "text": "Type III"
        },
        {
          "id": 4,
          "text": "Type IV"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Susceptibility of nerve fibers to hypoxia is <strong>B &gt;A&gt;C, </strong>and in the general classification, type IV sensory nerves are Type C fibers. </p><hr><h3>Related Pearl: Relative susceptibility of nerve fibres to conduction block by various agents</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Susceptibility</strong></p>\n</td>\n<td>\n<p><strong>Most susceptible</strong></p>\n</td>\n<td>\n<p><strong>Intermediate</strong></p>\n</td>\n<td>\n<p><strong>Least susceptible</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Local anaesthetic</p>\n</td>\n<td>\n<p>C</p>\n</td>\n<td>\n<p>B</p>\n</td>\n<td>\n<p>A</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypoxia</p>\n</td>\n<td>\n<p>B</p>\n</td>\n<td>\n<p>A</p>\n</td>\n<td>\n<p>C</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pressure</p>\n</td>\n<td>\n<p>A</p>\n</td>\n<td>\n<p>B</p>\n</td>\n<td>\n<p>C</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>\n<p><strong>Controversial: </strong>There is a difference in the opinion quoted by various standard textbooks and authors.</p>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p class=\"ng-binding\">According to Katzung pharmacology 14th edition page no. 465, <strong> B=C &gt; A delta &gt; A gamma &gt; A beta &gt; A alpha</strong></p>\n<p>Ganong's Physiology 26th edition, page no. 92, Nerve fibre most susceptible to local anesthetics is<strong> C &gt; B &gt; A</strong></p>\n</div>\n</div>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p>Hence, the correct answer would solely depend on the reference book the examiner referred to while making the question.</p>\n</div>\n</div>\n<p> </p><hr><h3>Related Pearl: Types of mammalian nerve fibres (Erlanger and Gasser's classification)</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Fiber type</strong></p>\n</td>\n<td>\n<p><strong>Function</strong></p>\n</td>\n<td>\n<p><strong>Fiber diameter(&mu;m)</strong></p>\n</td>\n<td>\n<p><strong>Conduction velocity(m/s)</strong></p>\n</td>\n<td>\n<p><strong>Spike duration(ms)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>A&alpha;</p>\n</td>\n<td>\n<p>Proprioception, somatic motor</p>\n</td>\n<td>\n<p>12-20</p>\n</td>\n<td>\n<p>70-120</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>A&beta;</p>\n</td>\n<td>\n<p>Touch, pressure</p>\n</td>\n<td>\n<p>5-12</p>\n</td>\n<td>\n<p>30-70</p>\n</td>\n<td>\n<p>0.4-0.5</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>A&gamma;</p>\n</td>\n<td>\n<p>Motor to muscle spindles</p>\n</td>\n<td>\n<p>3-6</p>\n</td>\n<td>\n<p>15-30</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>A&delta;</p>\n</td>\n<td>\n<p>Pain, temperature</p>\n</td>\n<td>\n<p>2-5</p>\n</td>\n<td>\n<p>12-30</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>B</p>\n</td>\n<td>\n<p>Preganglionic autonomic</p>\n</td>\n<td>\n<p>&lt;3</p>\n</td>\n<td>\n<p>3-15</p>\n</td>\n<td>\n<p>1.2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>C</p>\n<p>Dorsal root</p>\n</td>\n<td>\n<p>Pain, temperature</p>\n</td>\n<td>\n<p>0.4-1.2</p>\n</td>\n<td>\n<p>0.5-2</p>\n</td>\n<td>\n<p>2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>C Sympathetic</p>\n</td>\n<td>\n<p>Post ganglionic sympathetic</p>\n</td>\n<td>\n<p>0.3-1.3</p>\n</td>\n<td>\n<p>0.7-2.3</p>\n</td>\n<td>\n<p>2</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Numerical classification of sensory nerve fibers</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Number </strong></p>\n</td>\n<td>\n<p><strong>Origin </strong></p>\n</td>\n<td>\n<p><strong>Fibre type</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ia</p>\n</td>\n<td>\n<p>Muscle Spindle, annulo-spiral ending</p>\n</td>\n<td>\n<p>A&alpha;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ib</p>\n</td>\n<td>\n<p>Golgi tendon organ</p>\n</td>\n<td>\n<p>A&alpha;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>II</p>\n</td>\n<td>\n<p>Muscle Spindle, flower spray ending; touch, pressure</p>\n</td>\n<td>\n<p>A&beta;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>III</p>\n</td>\n<td>\n<p>Pain and cold receptors; some touch receptors</p>\n</td>\n<td>\n<p>A&delta;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>IV</p>\n</td>\n<td>\n<p>Pain, temperature, and other receptors</p>\n</td>\n<td>\n<p>C</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1046",
      "difficulty": "medium"
    },
    {
      "text": "A female constable of a police station accused the sub-inspector in charge of seducing her to have intercourse with her. He should be charged under I.P.C _________",
      "choices": [
        {
          "id": 1,
          "text": "Section 376(A)"
        },
        {
          "id": 2,
          "text": "Section 376(B)"
        },
        {
          "id": 3,
          "text": "Section 376(C)"
        },
        {
          "id": 4,
          "text": "Section 376(D)"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The sub inspector should be charged under IPC section 376 C since it is a case of rape by a person with authority.</p>\n<p><strong>The latest Supreme Court guidelines on rape:</strong></p>\n<ul>\n<li>Minimum Punishment for Rape has been increased from 7 years (earlier) to <strong>10 years (updated)</strong>. The maximum punishment remains the same, i.e. life imprisonment.</li>\n<li>A <strong>new sub - section (3)</strong> has been added to Section 376, which prescribes the minimum punishment of 20 years for rape of a woman under 16 years of age.</li>\n<li>A <strong>new Section</strong> <strong>376AB</strong> has been inserted which prescribes the <strong>minimum punishment of 20 years</strong> rigorous imprisonment to a person committing <strong>rape on a woman less than 12 years</strong> of age.</li>\n<li><strong>New sections</strong> namely <strong>376DA and 376DB</strong> prescribe <strong>minimum punishment of life imprisonment</strong> for persons involved in <strong>gang rape of woman aged less than 16 years and 12 years</strong> respectively.</li>\n<li>Death penalty has been prescribed for gang rape on woman below 12 years of age.</li>\n</ul><hr><h3>Related Pearl: Sexual Offences</h3><div id=\"WEB_ANSWERS_STANDARD_RESULT_7_Ptr4YYr4CLnD5OUPu-i8mAY__4\"></div>\n<div>\n<table>\n<tbody>\n<tr>\n<td><strong>BNS Section</strong></td>\n<td><strong>Section it deals with</strong></td>\n<td>\n<p><strong>Punishment</strong></p>\n</td>\n<td><strong>Previous IPC section</strong></td>\n</tr>\n<tr>\n<td>63</td>\n<td>Definition of Rape</td>\n<td> </td>\n<td>375</td>\n</tr>\n<tr>\n<td>\n<p>64(1)</p>\n</td>\n<td>Punishment for Rape</td>\n<td>\n<p>Rigorous imprisonment of not less than 10 years which may extend to imprisonment for life.</p>\n</td>\n<td>376</td>\n</tr>\n<tr>\n<td>65(1)</td>\n<td>Persons committing the offence of rape on a woman under16 years of age</td>\n<td>Rigorous imprisonment of not less than 20 years which may extend to imprisonment for life.</td>\n<td>376</td>\n</tr>\n<tr>\n<td>66</td>\n<td>The person committing an offense of rape and inflicting injury which causes death or causes the woman to be in a persistent vegetative state.</td>\n<td>Rigorous imprisonment of not less than 20 years may extend to imprisonment for life or with death.</td>\n<td>376A</td>\n</tr>\n<tr>\n<td>65(2)</td>\n<td>The person committing an offense of rape on a woman under 12 years of age</td>\n<td>Rigorous imprisonment of not less than 20 years but which may extend to imprisonment for life with fine or with death</td>\n<td>376AB</td>\n</tr>\n<tr>\n<td>67</td>\n<td>Sexual intercourse by the husband upon his wife during separation, without her consent</td>\n<td>Imprisonment for not less than 2 years but which may extend to 7 years and with a fine.</td>\n<td>376B</td>\n</tr>\n<tr>\n<td>68</td>\n<td>Sexual intercourse by a person in authority (police officer, public servant, member of armed forces, management or staff of a jail, remand home or other places of custody and management or staff of a hospital) who induces or seduces any female inmate of such jail, remand home, place, or institution to have sexual intercourse with him, such sexual intercourse not amounting to the offense of rape.</td>\n<td>Rigorous imprisonment for not less than 5 years but which may extend to 10 years and with a fine.</td>\n<td>376C</td>\n</tr>\n<tr>\n<td>70(1)</td>\n<td>Gang Rape</td>\n<td>Rigorous imprisonment for not less than 20 years which may extend to imprisonment for life with fine</td>\n<td>376D</td>\n</tr>\n<tr>\n<td>70(2)</td>\n<td>Gang rape on a woman under 18 years of age</td>\n<td>Rigorous imprisonment for life and with fine</td>\n<td>376DA</td>\n</tr>\n<tr>\n<td>71</td>\n<td>Repeat offenders</td>\n<td>Imprisonment for life or with death</td>\n<td>376E</td>\n</tr>\n<tr>\n<td>74</td>\n<td>Assault or use of criminal force to woman with intent to outrage her modesty</td>\n<td>Imprisonment for not less than one year, extending up to five years and with fine.</td>\n<td>354</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div>\n<p> </p>\n<p>As per the The Gazette of India, from the Ministry of Law and Justice, Bharatiya Nyaya Sanhita Document 2023</p>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6399",
      "difficulty": "medium"
    },
    {
      "text": "Quadruple testing is done during:",
      "choices": [
        {
          "id": 1,
          "text": "9-11 weeks"
        },
        {
          "id": 2,
          "text": "12-14 weeks"
        },
        {
          "id": 3,
          "text": "15-20 weeks"
        },
        {
          "id": 4,
          "text": "22-28 weeks"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The <strong>quadruple screening test</strong> is ideally done in the second trimester, during <strong>15-20 weeks</strong> of gestation. The most <strong>accurate</strong> values are seen during <strong>16-18 weeks</strong> of gestation.&nbsp;</p>\n<p>It is the measurement of maternal serum alpha-fetoprotein (MSAFP), unconjugated estriol, hCG, and inhibin-A.&nbsp;</p>\n<p>In Down's syndrome (trisomy 21) or Edward's syndrome (trisomy 18), quadruple-marker screenings do not provide any added benefit over first-trimester screenings. It is generally used as a stand-alone test if screening is done for the first time in the second trimester or if first-trimester screening is not available.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>&nbsp;</strong></td>\n<td><strong>Trisomy 21</strong></td>\n<td><strong>Trisomy 18</strong></td>\n<td><strong>Neural tube defect or abdominal wall defect</strong></td>\n<td><strong>Trisomy 13/ Patau syndrome</strong></td>\n</tr>\n<tr>\n<td><strong>MSAFP</strong></td>\n<td>Low</td>\n<td>Low</td>\n<td><strong>High</strong></td>\n<td>&nbsp;Normal</td>\n</tr>\n<tr>\n<td><strong>&beta; hCG</strong></td>\n<td><strong>High</strong></td>\n<td>Low</td>\n<td>Normal</td>\n<td>&nbsp;Normal</td>\n</tr>\n<tr>\n<td><strong>Unconjugated estriol</strong></td>\n<td>Low</td>\n<td>Low</td>\n<td>Normal</td>\n<td>&nbsp;Normal</td>\n</tr>\n<tr>\n<td><strong>Inhibin A</strong></td>\n<td><strong>High</strong></td>\n<td>Normal/Low</td>\n<td>Normal</td>\n<td>&nbsp;<strong>High</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4285",
      "difficulty": "medium"
    },
    {
      "text": "The replacement dose of hydrocortisone for chronic adrenal insufficiency is (in mg/day):",
      "choices": [
        {
          "id": 1,
          "text": "10"
        },
        {
          "id": 2,
          "text": "12"
        },
        {
          "id": 3,
          "text": "20"
        },
        {
          "id": 4,
          "text": "5"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The <strong>replacement dose</strong> of hydrocortisone for <strong>chronic adrenal insufficiency</strong> is <strong>2</strong><strong>0 mg/day.</strong></p>\n<p>The treatment of chronic adrenal insufficiency (<strong>not in crisis</strong>) requires glucocorticoid replacement at a dose that replaces the physiologic daily cortisol production. This is achieved by administering an oral replacement dose of 15-25mg Hydrocortisone. <br />A <strong>midpoint dose of 20mg</strong> is given in 2-3 divided doses: <strong>10mg + 5mg + 5mg</strong>. <br />Half the daily dose should be administered to all patients in the morning. This is to follow the normal circadian rhythm. </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3688",
      "difficulty": "medium"
    },
    {
      "text": "A psychiatrist is conducting the Folstein test as a part of the psychiatric evaluation of a patient. What is the maximum score out of which the patient is scored?",
      "choices": [
        {
          "id": 1,
          "text": "15"
        },
        {
          "id": 2,
          "text": "25"
        },
        {
          "id": 3,
          "text": "20"
        },
        {
          "id": 4,
          "text": "30"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The <strong>Mini-Mental State Examination (MMSE),&nbsp;</strong>also known as<strong>&nbsp;</strong>the<strong> Folstein test,</strong> is scored out of&nbsp;<strong>30. </strong>It consists of a&nbsp;questionnaire from 11 categories. It&nbsp;is used extensively in clinical and research settings to test cognitive functioning.</p>\n<p class=\"p1\">A patient with a score <strong>less than 24</strong> is considered to have <strong>impaired cognition.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f18ac6e203bd48989fbbaf070a4e6346x1280x1926.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3378",
      "difficulty": "easy"
    },
    {
      "text": "What is the natural resonance of the tympanic membrane?",
      "choices": [
        {
          "id": 1,
          "text": "3000 Hz"
        },
        {
          "id": 2,
          "text": "800-1600 Hz"
        },
        {
          "id": 3,
          "text": "1500-2000 Hz"
        },
        {
          "id": 4,
          "text": "2000-3000 Hz"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The <strong>natural resonance</strong> of the <strong>tympanic membrane</strong> is <strong>800 &ndash; 1600 Hz.</strong></p>\n<p>Aging causes a decrease in the external ear resonance amplitude due to the collapse of the external auditory canal and the tympanic membrane becoming senile. This factor has to be considered to appropriately diagnose hearing loss and in the selection of hearing aids.</p>\n<p><strong>Natural resonance and efficiency of auditory apparatus:</strong></p>\n<ul>\n<li>External auditory canal- 3000 Hz</li>\n<li>Tympanic membrane- 800&ndash;1600 Hz</li>\n<li>Middle ear- 800 Hz</li>\n<li>Ossicular chain- 500&ndash;2000 Hz</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8870",
      "difficulty": "medium"
    }
  ]
}